title: MCF10A shNT YAP/TAZ cDNA replicate 1

source_name: MCF10A shNT YAP/TAZ cDNA replicate 1


title: MCF10A shNT ESR1 cDNA replicate 1

status: Public on Jan 27 2017

type: RNA

city: Basel

first: Tim

last: Roloff

address: Maulbeerstrasse 66

department: Functional Genomics

country: Switzerland

institute: FMI

hyb_protocol: Hybridization was carried out with 2.55 μg of biotinylated target, which was incubated with a GeneChip human Gene 1.0 ST Array (Affymetrix) at 45°C for 16 h.  Following hybridization, non-specifically bound nucleotides were removed by washing and specifically bound target detected using a GeneChip Hybridization, Wash and Stain kit and a GeneChip Fluidics Station 450 (Affymetrix).

scan_protocol: The arrays were scanned using a GeneChip Scanner 3000 7G (Affymetrix) and CEL files acquired using GeneChip Command Console Software (Affymetrix).

data_processing: Arrays were normalized and probeset-level expression values calculated with R/Bioconductor's (v2.1415.3/v2.11) 'affy' package using the justRMA() function

label: Biotin

molecule: total RNA

organism: Homo sapiens

source_name: MCF10A shNT ESR1 cDNA replicate 1

label_protocol: 100 ng  total RNA were processed with the Ambion WT Expression Kit (Thermo Fischer Scientific) and 2.75 μg of the resulting cDNA were fragmented and labeled with the Affymetrix GeneChip WT Terminal Labeling and Hybridization kit (Affymetrix).

growth_protocol: MCF10A cells were routinely cultured as described in the methods section, for the experiment, they were cultured in M5 estrogen containing medium.

extract_protocol: RNeasy Plus Mini Kit was used according to the manufacture's protocol

treatment_protocol: MCF10A cells were infected at an MOI of 5 with either with the pLKO non-targeting shRNA control lentivirus (shNT), lentivirus targeting LATS1 (shLATS1B) or lentivirus targeting LATS1 and LATS2 (shLATS1+2). Cells were selected with Puromycin at 1.5µg / ml for 4days. The medium was exchanged and the cells were allowed to recover for at least 7days. They were then transiently transfected with cDNA vectors according to the Lipofectamine2000 protocol and cultured in M5 for 5 days before lysis and RNA extraction (Quiagen).

tag: cell line

tag: cell type

value: mammary epithelial cell


title: MCF10A shLATS1B ctrl cDNA replicate 3

source_name: MCF10A shLATS1B ctrl cDNA replicate 3


title: MCF10A shNT YAP/TAZ cDNA replicate 2

source_name: MCF10A shNT YAP/TAZ cDNA replicate 2


title: MCF10A shNT ctrl cDNA replicate 2

source_name: MCF10A shNT ctrl cDNA replicate 2


title: MCF10A shNT ctrl cDNA replicate 1

source_name: MCF10A shNT ctrl cDNA replicate 1


title: MCF10A shNT YAP/TAZ ESR1 cDNA replicate 1


title: MCF10A shNT YAP/TAZ ESR1 cDNA replicate 2


title: PHBEC_MP20_shLATS1and2

hyb_protocol: Affymetrix Gene Chip Arrays were hybridized following the GeneChip Whole Transcript (WT) Sense Target Labeling Assay Manual (Affymetrix) with a hybridization time of 16h. The Affymetrix Fluidiscs protocol FS450_0007 was used for washing.

scan_protocol: Scanning was performed with Affzmetrix GCC Scan Control v. 3.0.0.1214 on a GeneChip Scanner 3000 with autoloader

data_processing: Arrays were normalized and probeset-level expression values were calculated with R/Bioconductor's (v2.15) 'affy' package using the rma() function

label: biotin

source_name: normal breast tissue

label_protocol: 200ng of extracted total RNA was amplified using the Ambion WT Expression kit (Ambion) and the resulting sense-strand cDNA was fragmented and labeled using the Affymetrix GeneChip WT Terminal Labeling kit (Affymetrix).

growth_protocol: Reduction mammoplasties were processed as described in the experimental procedures. The resulting single cells (primary human breast epithelial cells, PHBECs) were grown in suspension in M5 medium.

treatment_protocol: PHBECs were infected in suspension at an MOI of 25 with either with the pLKO non-targeting shRNA control lentivirus (shNT), lentivirus targeting LATS1 (shLATS1_3) or lentivirus targeting LATS1 and LATS2 (shLATS2_3). Cells were selected with Puromycin at 1.5µg / ml, after 7days the resulting spheres were dissociated and grown on primaria plates for 10 days before lysis and RNA extraction.

tag: individual

value: donor MP20

value: normal breast epithelial cells

tag: genotype/variation

value: LATS1 and LATS2 double knockdown


title: MCF10A shNT YAP/TAZ cDNA replicate 3

source_name: MCF10A shNT YAP/TAZ cDNA replicate 3


title: PHBEC_MP16_shLATS1

value: donor MP16

value: LATS1 knockdown


title: PHBEC_MP20_shLATS1


title: PHBEC_MP20_shNT_2

value: control


title: PHBEC_MP28_shLATS1

value: donor MP28


title: peripheral blood sample obtained from celiac patient DY (140145_DYv2)

city: Stanford

first: Mitchell

middle: E

last: Garber

state: CA

address: 333 Campus Drive

department: Chemistry

country: USA

institute: Stanford University

hyb_protocol: Standard Illumina hybridization protocol

scan_protocol: Standard Illumina scanning protocol

data_processing: Data were batch normalized to account for the microarray hybridations on four different days using two Illumina platforms HT12v3 (GPL6947) and HT12v4 (GPL10558). Only probes having identical sequence content between versions were retained. Potential artifacts due to the two array versions and batch were removed by assuming the batch medians for a given probe were equal (covariates were not associated with batch). After median shifting each probe relative to batch medians, probe quantile normalization was performed across all samples.  Background was then subtracted with a monotonic transform of probe values below background to the (0,1) interval so that all normalized probes had positive values prior to log transformation. After normalization, batch adjustment and background subtraction, the difference in expression between baseline and six-week time points was calculated as log2(six-weeks) minus log2(baseline) for each subject resulting in a matrix of 20,624 features and 73 samples. Normalized log2 transformed data is provided here for both baseline (v2) and six-week samples (v6) prior to the subtraction. Normalized dataset consists of 146 experiments representing 73 patients, with each patient having two samples.

source_name: purified pool of B and T cells obtained from peripheral blood,  at baseline time 0

label_protocol: Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays

extract_protocol: RNA was extracted with Trizol reagent, followed by clean-up and spin column to eliminate contaminating DNA using the QIAGEN RNeasy mini kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.

value: celiac patient DY

tag: disease state

value: biopsy confirmed celiac disease on gluten-free diet greater than one year

tag: treatment

tag: tissue

value: peripheral whole blood

value: purified pool of B and T cells

tag: biopsy data, villus height to crypt depth

tag: hybridization batch


title: PHBEC_MP16_shNT_2


title: peripheral blood sample obtained from celiac patient DZ (140148_DZv2)

value: celiac patient DZ


title: PHBEC_MP16_shNT_1


title: peripheral blood sample obtained from celiac patient DX (140142_DXv2)

value: celiac patient DX


title: peripheral blood sample obtained from celiac patient DW (140139_DWv2)

value: celiac patient DW


title: PHBEC_MP20_shNT_1


title: PHBEC_MP22_shLATS1and2

value: donor MP22


title: peripheral blood sample obtained from celiac patient DX (140144_DXv6)

source_name: purified pool of B and T cells obtained from peripheral blood,  after 6 weeks gluten challenge

value: 6 weeks gluten challenge


title: peripheral blood sample obtained from celiac patient DY (140147_DYv6)


title: peripheral blood sample obtained from celiac patient DR (140138_DRv6)

value: celiac patient DR


title: peripheral blood sample obtained from celiac patient DZ (140150_DZv6)


title: PHBEC_MP16_shLATS1and2


title: PHBEC_MP28_shNT_2


title: peripheral blood sample obtained from celiac patient DW (140141_DWv6)


title: peripheral blood sample obtained from celiac patient T (140154_Tv2)

value: celiac patient T


title: peripheral blood sample obtained from celiac patient DR (140136_DRv2)


title: peripheral blood sample obtained from celiac patient DM (140126_DMv6)

value: celiac patient DM


title: peripheral blood sample obtained from celiac patient DQ (140135_DQv6)

value: celiac patient DQ


title: peripheral blood sample obtained from celiac patient DP (140132_DPv6)

value: celiac patient DP


title: peripheral blood sample obtained from celiac patient DN (140129_DNv6)

value: celiac patient DN


title: peripheral blood sample obtained from celiac patient DK (140123_DKv6)

value: celiac patient DK


title: peripheral blood sample obtained from celiac patient DN (140127_DNv2)

value: control


title: peripheral blood sample obtained from celiac patient DK (140121_DKv2)


title: peripheral blood sample obtained from celiac patient DJ (140118_DJv2)

value: celiac patient DJ


title: peripheral blood sample obtained from celiac patient DP (140130_DPv2)

value: biopsy confirmed celiac disease on gluten-free diet greater than one year


title: peripheral blood sample obtained from celiac patient DM (140124_DMv2)

value: peripheral whole blood


title: peripheral blood sample obtained from celiac patient DH (140115_DHv2)

value: celiac patient DH

value: purified pool of B and T cells


title: peripheral blood sample obtained from celiac patient DQ (140133_DQv2)


title: peripheral blood sample obtained from celiac patient DG (140114_DGv6)

value: celiac patient DG


title: peripheral blood sample obtained from celiac patient DH (140117_DHv6)


title: peripheral blood sample obtained from celiac patient DC (140105_DCv6)

value: celiac patient DC


title: peripheral blood sample obtained from celiac patient DF (140111_DFv6)

value: celiac patient DF


title: peripheral blood sample obtained from celiac patient DB (140102_DBv6)

value: celiac patient DB

value: 6 weeks gluten challenge


title: peripheral blood sample obtained from celiac patient DC (140103_DCv2)


title: peripheral blood sample obtained from celiac patient DB (140100_DBv2)


title: peripheral blood sample obtained from celiac patient DA (140099_DAv6)

value: celiac patient DA


title: peripheral blood sample obtained from celiac patient DJ (140120_DJv6)


title: peripheral blood sample obtained from celiac patient CX (114484@N3_CXv2)

value: celiac patient CX


title: peripheral blood sample obtained from celiac patient CT (114498@N3_CTv6)

value: celiac patient CT


title: peripheral blood sample obtained from celiac patient DF (140109_DFv2)


title: peripheral blood sample obtained from celiac patient CX (121785_CXv6)


title: peripheral blood sample obtained from celiac patient CT (114496@N3_CTv2)


title: peripheral blood sample obtained from celiac patient DG (140112_DGv2)


title: peripheral blood sample obtained from celiac patient CS (121761_CSv2)

value: celiac patient CS


title: peripheral blood sample obtained from celiac patient CM (121767_CMv6)

value: celiac patient CM


title: peripheral blood sample obtained from celiac patient DA (140097_DAv2)


title: peripheral blood sample obtained from celiac patient CN (121762_CNv6)

value: celiac patient CN


title: peripheral blood sample obtained from celiac patient CJ (121764_CJv6)

value: celiac patient CJ


title: peripheral blood sample obtained from celiac patient CM (114502@N3_CMv2)

value: control


title: peripheral blood sample obtained from celiac patient CE (114483@N3_CEv6)

value: celiac patient CE

value: biopsy confirmed celiac disease on gluten-free diet greater than one year


title: peripheral blood sample obtained from celiac patient CE (121783_CEv2)

value: peripheral whole blood


title: peripheral blood sample obtained from celiac patient CG (121766_CGv6)

value: celiac patient CG

value: purified pool of B and T cells


title: peripheral blood sample obtained from celiac patient CG (114499@N3_CGv2)


title: peripheral blood sample obtained from celiac patient CB (114490@N3_CBv2)

value: celiac patient CB


title: peripheral blood sample obtained from celiac patient CN (121786_CNv2)


title: peripheral blood sample obtained from celiac patient CS (114480@N3_CSv6)


title: peripheral blood sample obtained from celiac patient AY (114458@N3_AYv6)

value: celiac patient AY


title: peripheral blood sample obtained from celiac patient BK (121780_BKv6)

value: celiac patient BK


title: peripheral blood sample obtained from celiac patient CJ (121787_CJv2)


title: peripheral blood sample obtained from celiac patient AY (114457@N3_AYv2)


title: peripheral blood sample obtained from celiac patient CB (121763_CBv6)

value: 6 weeks gluten challenge


title: peripheral blood sample obtained from celiac patient AW (114463@N3_AWv2)

value: celiac patient AW


title: peripheral blood sample obtained from celiac patient CA (114505@N3_CAv2)

value: celiac patient CA


title: peripheral blood sample obtained from celiac patient AW (114465@N3_AWv6)


title: peripheral blood sample obtained from celiac patient AV (121760_AVv6)

value: celiac patient AV


title: peripheral blood sample obtained from celiac patient CA (114507@N3_CAv6)


title: peripheral blood sample obtained from celiac patient AX (114473@N3_AXv6)

value: celiac patient AX


title: peripheral blood sample obtained from celiac patient AV (121759_AVv2)


title: peripheral blood sample obtained from celiac patient AS (114439@N3_ASv2)

value: celiac patient AS


title: peripheral blood sample obtained from celiac patient AU (114408@N3_AUv6)

value: celiac patient AU


title: peripheral blood sample obtained from celiac patient AR (114442@N3_ARv2)

value: celiac patient AR


title: peripheral blood sample obtained from celiac patient BK (114466@N3_BKv2)

value: control


title: peripheral blood sample obtained from celiac patient AT (114411@N3_ATv6)

value: celiac patient AT


title: peripheral blood sample obtained from celiac patient AX (121758_AXv2)

value: biopsy confirmed celiac disease on gluten-free diet greater than one year


title: peripheral blood sample obtained from celiac patient AQ (114425@N3_AQv2)

value: celiac patient AQ

value: peripheral whole blood


title: peripheral blood sample obtained from celiac patient AS (114441@N3_ASv6)

value: purified pool of B and T cells


title: peripheral blood sample obtained from celiac patient AT (114409@N3_ATv2)


title: peripheral blood sample obtained from celiac patient AQ (121770_AQv6)


title: peripheral blood sample obtained from celiac patient AR (114444@N3_ARv6)


title: peripheral blood sample obtained from celiac patient AP (114454@N3_APv2)

value: celiac patient AP


title: peripheral blood sample obtained from celiac patient AU (114406@N3_AUv2)


title: peripheral blood sample obtained from celiac patient AN (114415@N3_ANv6)

value: celiac patient AN


title: peripheral blood sample obtained from celiac patient AJ (114416@N3_AJv2)

value: celiac patient AJ


title: peripheral blood sample obtained from celiac patient AK (114437@N3_AKv2)

value: celiac patient AK


title: peripheral blood sample obtained from celiac patient AN (114414@N3_ANv2)


title: peripheral blood sample obtained from celiac patient AO (114419@N3_AOv2)

value: celiac patient AO


title: peripheral blood sample obtained from celiac patient AP (114456@N3_APv6)

value: 6 weeks gluten challenge


title: peripheral blood sample obtained from celiac patient AL (114413@N3_ALv6)

value: celiac patient AL


title: peripheral blood sample obtained from celiac patient AO (114421@N3_AOv6)


title: peripheral blood sample obtained from celiac patient AM (114447@N3_AMv6)

value: celiac patient AM


title: peripheral blood sample obtained from celiac patient AM (114445@N3_AMv2)


title: peripheral blood sample obtained from celiac patient AL (114412@N3_ALv2)


title: peripheral blood sample obtained from celiac patient AJ (114418@N3_AJv6)


title: peripheral blood sample obtained from celiac patient AH (121774_AHv6)

value: celiac patient AH


title: peripheral blood sample obtained from celiac patient AI (114434@N3_AIv2)

value: celiac patient AI


title: peripheral blood sample obtained from celiac patient AK (114438@N3_AKv6)


title: peripheral blood sample obtained from celiac patient AG (114453@N3_AGv6)

value: celiac patient AG


title: peripheral blood sample obtained from celiac patient AG (114451@N3_AGv2)

value: control


title: peripheral blood sample obtained from celiac patient AF (114405@N3_AFv6)

value: celiac patient AF


title: peripheral blood sample obtained from celiac patient AE (114448@N3_AEv2)

value: celiac patient AE

value: biopsy confirmed celiac disease on gluten-free diet greater than one year


title: peripheral blood sample obtained from celiac patient AD (114402@N3_ADv6)

value: celiac patient AD

value: peripheral whole blood


title: peripheral blood sample obtained from celiac patient AH (114459@N3_AHv2)

value: purified pool of B and T cells


title: peripheral blood sample obtained from celiac patient AE (114450@N3_AEv6)


title: peripheral blood sample obtained from celiac patient AC (121771_ACv6)

value: celiac patient AC


title: peripheral blood sample obtained from celiac patient AC (114428@N3_ACv2)


title: peripheral blood sample obtained from celiac patient AI (114436@N3_AIv6)


title: peripheral blood sample obtained from celiac patient AD (114400@N3_ADv2)


title: peripheral blood sample obtained from celiac patient AF (114403@N3_AFv2)


title: peripheral blood sample obtained from celiac patient AA (114433@N3_AAv6)

value: celiac patient AA


title: peripheral blood sample obtained from celiac patient AA (114431@N3_AAv2)


title: peripheral blood sample obtained from celiac patient AB (121769_ABv6)

value: celiac patient AB


title: peripheral blood sample obtained from celiac patient AB (114422@N3_ABv2)


title: 0GyF1/ reference male mouse2

type: genomic

city: Rokkasho-mura,Kamikita-gun,

first: Keiji

last: OGURA

state: Aomori

address: Takahoko, Hacchasawa,

department: Department of Radiobiology

country: Japan

institute: Institute for Environmental Science

hyb_protocol: Oligonucleotide Array-Based CGH for Genomic DNA Analysis, protocol version 4.0.8

scan_protocol: Scanned on an Agilent G2565BA scanner. Images were quantified using Agilent Feature Extraction Software (version 10.7.1.1).

data_processing: Agilent Genomic Workbench Software (v 7.0.) was used.

molecule: genomic DNA

organism: Mus musculus

extract_protocol: PI-50a (Kurabo Industries LTD.) tissue DNA extraction protocol.

tag: strain

value: tail

source_name: reference male mouse2


title: reference male mouse2/ 0GyF1

label_protocol: Oligonucleotide Array-Based CGH for Genomic DNA Analysis, protocol version 4.0.8


title: reference male mouse2/ 0GyF2


title: 0GyF2/ reference male mouse2


title: 0GyFF/ reference male mouse2


title: reference male mouse2/ 0GyD2


title: 0GyD3/ reference male mouse2


title: 0GyD1/ reference male mouse2


title: 0GyDF/ reference male mouse2


title: reference male mouse2/ 0GyD4


title: reference male mouse2/ 0GyDM


title: reference male mouse2/ 0GyFM


title: reference male mouse2/ 0GyD3


title: reference male mouse2/ 0GyDF


title: 0GyF4/ reference male mouse2


title: 0GyF7/ reference male mouse2


title: reference male mouse2/ 0GyF4


title: reference male mouse2/ 0GyD1


title: 0GyD2/ reference male mouse2


title: reference male mouse2/ 0GyF3


title: 0GyD4/ reference male mouse2


title: reference male mouse2/ 0GyF6


title: 0GyDM/ reference male mouse2


title: 0GyF6/ reference male mouse2


title: reference male mouse2/ 0GyF7


title: 0GyF3/ reference male mouse2


title: reference male mouse2/ 0GyF5


title: SS1 A1 7438.P27

city: Lund

first: Mikael

middle: Nils Erik

last: Sommarin

state: skåne

address: klinikgatan 26, BMC B12

department: Department of molecular hematology

country: Sweden

institute: Lund university

description:
CML_Plate1_PatNr.11_Dx
All patients included in this dataset responded well to TKI, but leukemic cells (Ph+) can still be detected in patient bone marrow.

data_processing: Ct values calculated and exported using Fluidigm Biomark software. Data normalized by subtraction of the median Ct per cell followed by z-score scaling.

label: FAM-MGB

source_name: CML Bone Marrow HSC

label_protocol: cDNA synthesis and amplification was performed by adding a mix of 96 Taqman assays with a final concentration of 0.025x and Taq/SSIII enzyme reaction mix (CellsDirect One-Step RT-qPCR kit, Invitrogen) and PCR cycling was performed as follows, cDNA synthesis: 60min at 50oC and 2 min at 95oC, amplification:  15sec at 95oC and 4 min at 60oC repeated 25 times.  The cDNA was diluted 5 times with water prior to qPCR on the BioMark HD (Fluidigm Corporation, San Francisco, CA). All primers were used at 12.5x in the final reaction and Taqman universal master mix (Applied Biosystems, Foster City, CA) was used for detection of the qPCR products. The qPCR was performed using the 96.96 Dynamic Array Integrated Fluidic Circuits (IFC) (Fluidigm Corporation, San Francisco, CA) chip in combination with the BioMark HD with the following thermal cycler program: thermal mix 50°C for 2 minutes followed by 70°C for 30 minutes and 25°C for 10 minutes, UNG at 50°C for 2 minutes, hot start 96.5°C for 10 minutes, PCR cycle 40x (96°C 15 seconds, 60°C for 60 seconds).

extract_protocol: Cells were sorted into 96 well plates with 4µl lysis buffer (Neuclease free water, RNAsout (Invitrogen), 0.1M DTT, 10mM dNTP, 10% NP40)  and immediately frozen at -80°C.

treatment_protocol: Single cell suspension of cells were FACS sorted to obtain HSC cells

value: CML

tag: clinical phase

value: at diagnosis (Dx)

tag: therapy-response

value: CML Bone Marrow HSC

tag: cell subtype


title: ss43 D7 684.P27

description:
CML_Plate1_PatNr.9_Dx
All patients included in this dataset responded well to TKI, but leukemic cells (Ph+) can still be detected in patient bone marrow.


title: 0GyF5/ reference male mouse2


title: SS2 A2 7438.P27


title: ss44 D8 684.P27


title: ss45 D9 684.P27


title: 0GyFM/ reference male mouse2


title: SS3 A3 7438.P27


title: reference male mouse2/ 0GyFF


title: SS4 A4 7438.P27


title: ss46 D10 684.P27


title: SS5 A5 7438.P27


title: SS6 A6 7438.P27


title: ss47 D11 684.P27


title: ss48 D12 684.P27


title: SS7 A7 7438.P27


title: ss38 D2 684.P27


title: ss39 D3 684.P27


title: SS9 A9 7438.P27


title: SS11 A11 7438.P27


title: ss37 D1 684.P27


title: ss40 D4 684.P27


title: SS10 A10 7438.P27


title: ss42 D6 684.P27


title: SS13 B1 7438.P27


title: ss32 C8 684.P27


title: ss33 C9 684.P27


title: SS14 B2 7438.P27


title: ss18 B6 7438.P27


title: SS15 B3 7438.P27


title: ss16 B4 7438.P27


title: ss19 B7 7438.P27


title: SS8 A8 7438.P27


title: ss34 C10 684.P27


title: ss26 C2 684.P27


title: ss28 C4 684.P27


title: ss20 B8 7438.P27


title: ss29 C5 684.P27


title: ss22 B10 7438.P27


title: ss25 C1 684.P27


title: ss24 B12 7438.P27


title: ss27 C3 684.P27


title: ss23 B11 7438.P27


title: ss21 B9 7438.P27


title: ss41 D5 684.P27


title: ss20 B8 684.P27


title: ss27 C3 7438.P27


title: ss31 C7 684.P27


title: ss22 B10 684.P27


title: ss26 C2 7438.P27


title: ss21 B9 684.P27


title: ss25 C1 7438.P27


title: ss19 B7 684.P27


title: ss29 C5 7438.P27


title: ss23 B11 684.P27


title: ss24 B12 684.P27


title: ss30 C6 7438.P27


title: ss31 C7 7438.P27


title: SS13 B1 684.P27


title: ss16 B4 684.P27


title: SS14 B2 684.P27


title: SS15 B3 684.P27


title: ss32 C8 7438.P27


title: ss34 C10 7438.P27


title: ss35 C11 7438.P27


title: ss17 B5 684.P27


title: SS7 A7 684.P27


title: ss38 D2.P27


title: SS9 A9 684.P27


title: SS8 A8 684.P27


title: SS10 A10 684.P27


title: ss39 D3 7438.P27


title: ss41 D5 7438.P27


title: ss28 C4 7438.P27


title: ss40 D4 7438.P27


title: SS11 A11 684.P27


title: ss42 D6 7438.P27


title: SS12 A12 684.P27


title: ss45 D9 7438.P27


title: ss36 C12 7438.P27


title: ss37 D1 7438.P27


title: ss18 B6 684.P27


title: SS6 A6 684.P27


title: SS5 A5 684.P27


title: ss47 D11 7438.P27


title: SS4 A4 684.P27


title: ss46 D10 7438.P27


title: ss43 D7.P26

description:
CML_Plate2_PatNr.15_Dx
All patients included in this dataset responded well to TKI, but leukemic cells (Ph+) can still be detected in patient bone marrow.


title: SS3 A3 684.P27


title: SS2 A2 684.P27


title: ss44 D8 7438.P27


title: ss44 D8.P26


title: ss50 E2.P26


title: ss49 E1.P26


title: ss45 D9.P26


title: ss47 D11.P26


title: SS1 A1 684.P27


title: ss55 E7.P26


title: ss48 D12.P26


title: ss52 E4.P26


title: ss38 D2.P26


title: ss56 E8.P26


title: ss58 E10.P26


title: ss40 D4.P26


title: ss30 C6 684.P27


title: ss57 E9.P26


title: ss59 E11.P26


title: ss42 D6.P26


title: ss31 C7.P26


title: ss60 E12.P26


title: ss62 F2.P26


title: ss36 C12.P26


title: ss65 F5.P26


title: ss53 E5.P26


title: ss64 F4.P26


title: ss66 F6.P26


title: ss32 C8.P26


title: ss61 F1.P26


title: ss25 C1.P26


title: ss33 C9.P26


title: ss63 F3.P26


title: ss34 C10.P26


title: ss26 C2.P26


title: ss67 F7.P26


title: ss68 F8.P26


title: ss51 E3.P26


title: ss27 C3.P26


title: ss35 C11.P26


title: ss70 F10.P26


title: ss28 C4.P26


title: ss29 C5.P26


title: ss41 D5.P26


title: ss30 C6.P26


title: ss19 B7.P26


title: ss74 G2.P26


title: ss73 G1.P26


title: ss72 F12.P26


title: ss23 B11.P26


title: ss76 G4.P26


title: SS14 B2.P26


title: ss20 B8.P26


title: ss75 G3.P26


title: ss77 G5.P26


title: ss24 B12.P26


title: ss71 F11.P26


title: ss84 G12.P26


title: ss18 B6.P26


title: ss16 B4.P26


title: SS7 A7.P26


title: SS9 A9.P26


title: SS8 A8.P26


title: ss80 G8.P26


title: ss83 G11.P26


title: SS15 B3.P26


title: ss17 B5.P26


title: SS11 A11.P26


title: ss88 H4.P26


title: ss87 H3.P26


title: SS10 A10.P26


title: ss21 B9.P26


title: SS13 B1.P26


title: ss81 G9.P26


title: ss91 H7.P26


title: SS1 A1.P26


title: ss90 H6.P26


title: SS3 A3.P26


title: ss43 D7.P25

description:
CML_Plate1_PatNr.10_Dx
All patients included in this dataset responded well to TKI, but leukemic cells (Ph+) can still be detected in patient bone marrow.


title: ss50 E2.P25


title: ss44 D8.P25


title: ss92 H8.P26


title: ss45 D9.P25


title: ss51 E3.P25


title: ss49 E1.P25


title: ss47 D11.P25


title: ss55 E7.P25


title: ss52 E4.P25


title: ss53 E5.P25


title: ss40 D4.P25


title: ss56 E8.P25


title: SS12 A12.P26


title: ss37 D1.P25


title: ss58 E10.P25


title: ss41 D5.P25


title: ss54 E6.P25


title: ss48 D12.P25


title: ss57 E9.P25


title: ss42 D6.P25


title: SS5 A5.P26


title: ss59 E11.P25


title: ss60 E12.P25


title: ss39 D3.P25


title: ss61 F1.P25


title: ss31 C7.P25


title: ss32 C8.P25


title: ss33 C9.P25


title: ss34 C10.P25


title: ss63 F3.P25


title: ss62 F2.P25


title: ss38 D2.P25


title: ss35 C11.P25


title: ss64 F4.P25


title: ss65 F5.P25


title: ss25 C1.P25


title: ss66 F6.P25


title: ss26 C2.P25


title: ss67 F7.P25


title: ss27 C3.P25


title: ss36 C12.P25


title: ss28 C4.P25


title: ss71 F11.P25


title: ss72 F12.P25


title: ss70 F10.P25


title: ss30 C6.P25


title: ss19 B7.P25


title: ss73 G1.P25


title: ss69 F9.P25


title: ss20 B8.P25


title: ss75 G3.P25


title: ss21 B9.P25


title: ss76 G4.P25


title: ss22 B10.P25


title: ss74 G2.P25


title: ss78 G6.P25


title: SS13 B1.P25


title: ss79 G7.P25


title: ss24 B12.P25


title: ss68 F8.P25


title: ss77 G5.P25


title: ss23 B11.P25


title: ss29 C5.P25


title: SS15 B3.P25


title: ss81 G9.P25


title: ss80 G8.P25


title: ss16 B4.P25


title: ss17 B5.P25


title: ss82 G10.P25


title: ss83 G11.P25


title: ss84 G12.P25


title: SS9 A9.P25


title: SS10 A10.P25


title: ss18 B6.P25


title: SS8 A8.P25


title: SS7 A7.P25


title: SS14 B2.P25


title: SS11 A11.P25


title: SS12 A12.P25


title: ss89 H5.P25


title: ss91 H7.P25


title: SS2 A2.P25


title: ss43 D7.P24

description:
CML_Plate1_PatNr.12_TKI
All patients included in this dataset responded well to TKI, but leukemic cells (Ph+) can still be detected in patient bone marrow.

value: after TKI treatment (TKI)

value: Ph+ detected in BM (but all cells are not Ph+)


title: SS6 A6.P25


title: ss92 H8.P25


title: SS4 A4.P25


title: SS3 A3.P25


title: ss44 D8.P24


title: ss45 D9.P24


title: ss50 E2.P24


title: ss46 D10.P24


title: ss47 D11.P24


title: ss53 E5.P24


title: ss52 E4.P24


title: ss48 D12.P24


title: ss37 D1.P24


title: ss55 E7.P24


title: ss56 E8.P24


title: ss38 D2.P24


title: SS1 A1.P25


title: ss39 D3.P24


title: ss57 E9.P24


title: ss58 E10.P24


title: ss59 E11.P24


title: ss51 E3.P24


title: ss31 C7.P24


title: ss42 D6.P24


title: ss60 E12.P24


title: ss64 F4.P24


title: ss62 F2.P24


title: ss33 C9.P24


title: ss32 C8.P24


title: ss34 C10.P24


title: ss66 F6.P24


title: ss35 C11.P24


title: ss65 F5.P24


title: ss36 C12.P24


title: ss40 D4.P24


title: ss63 F3.P24


title: ss26 C2.P24


title: ss67 F7.P24


title: ss27 C3.P24


title: ss68 F8.P24


title: ss28 C4.P24


title: ss69 F9.P24


title: ss41 D5.P24


title: ss70 F10.P24


title: ss29 C5.P24


title: ss72 F12.P24


title: ss71 F11.P24


title: ss19 B7.P24


title: ss73 G1.P24


title: ss20 B8.P24


title: ss89 H5.P26


title: ss76 G4.P24


title: ss21 B9.P24


title: ss74 G2.P24


title: ss22 B10.P24


title: ss78 G6.P24


title: ss24 B12.P24


title: ss77 G5.P24


title: ss23 B11.P24


title: SS15 B3.P24


title: ss80 G8.P24


title: SS14 B2.P24


title: SS13 B1.P24


title: ss16 B4.P24


title: ss81 G9.P24


title: ss79 G7.P24


title: ss84 G12.P24


title: ss30 C6.P24


title: ss18 B6.P24


title: ss75 G3.P24


title: SS7 A7.P24


title: SS8 A8.P24


title: SS9 A9.P24


title: ss88 H4.P24


title: SS10 A10.P24


title: ss82 G10.P24


title: ss87 H3.P24


title: ss89 H5.P24


title: SS1 A1.P24


title: SS12 A12.P24


title: ss90 H6.P24


title: SS11 A11.P24


title: SS2 A2.P24


title: SS5 A5.P24


title: ss50 E2.P23

description:
CML_Plate2_PatNr.14_Dx
All patients included in this dataset responded well to TKI, but leukemic cells (Ph+) can still be detected in patient bone marrow.


title: ss43 D7.P23


title: ss92 H8.P24


title: SS6 A6.P24


title: ss45 D9.P23


title: ss49 E1.P23


title: ss44 D8.P23


title: ss51 E3.P23


title: ss46 D10.P23


title: ss47 D11.P23


title: ss52 E4.P23


title: ss53 E5.P23


title: ss48 D12.P23


title: SS5 A5.P25


title: SS4 A4.P24


title: ss91 H7.P24


title: SS3 A3.P24


title: ss54 E6.P23


title: ss55 E7.P23


title: ss37 D1.P23


title: ss57 E9.P23


title: ss39 D3.P23


title: ss40 D4.P23


title: ss41 D5.P23


title: ss58 E10.P23


title: ss59 E11.P23


title: ss61 F1.P23


title: ss42 D6.P23


title: ss32 C8.P23


title: ss62 F2.P23


title: ss60 E12.P23


title: ss34 C10.P23


title: ss33 C9.P23


title: ss63 F3.P23


title: ss64 F4.P23


title: ss65 F5.P23


title: ss35 C11.P23


title: ss38 D2.P23


title: ss36 C12.P23


title: ss25 C1.P23


title: ss56 E8.P23


title: ss67 F7.P23


title: ss27 C3.P23


title: ss69 F9.P23


title: ss68 F8.P23


title: ss28 C4.P23


title: ss29 C5.P23


title: ss30 C6.P23


title: ss72 F12.P23


title: ss20 B8.P23


title: ss21 B9.P23


title: ss66 F6.P23


title: ss75 G3.P23


title: ss76 G4.P23


title: SS13 B1.P23


title: SS14 B2.P23


title: ss79 G7.P23


title: ss24 B12.P23


title: ss78 G6.P23


title: ss17 B5.P23


title: ss83 G11.P23


title: ss22 B10.P23


title: ss19 B7.P23


title: ss18 B6.P23


title: ss84 G12.P23


title: ss90 H6.P25


title: ss74 G2.P23


title: SS15 B3.P23


title: ss80 G8.P23


title: ss16 B4.P23


title: ss77 G5.P23


title: SS8 A8.P23


title: SS9 A9.P23


title: ss87 H3.P23


title: SS10 A10.P23


title: ss88 H4.P23


title: ss23 B11.P23


title: ss49 E1.P24


title: SS6 A6.P23


title: SS3 A3.P23


title: SS7 A7.P23


title: ss49 E1.P22

description:
CML_Plate1_PatNr.18_Dx_PB
All patients included in this dataset responded well to TKI, but leukemic cells (Ph+) can still be detected in patient bone marrow.

source_name: CML Peripheral Blood HSC

value: CML Peripheral Blood HSC


title: ss92 H8.P23


title: SS2 A2.P23


title: ss43 D7.P22


title: ss44 D8.P22


title: ss50 E2.P22


title: ss47 D11.P22


title: SS11 A11.P23


title: ss89 H5.P23


title: SS12 A12.P23


title: ss51 E3.P22


title: ss53 E5.P22


title: ss48 D12.P22


title: ss54 E6.P22


title: ss38 D2.P22


title: ss37 D1.P22


title: ss55 E7.P22


title: ss57 E9.P22


title: ss45 D9.P22


title: ss90 H6.P23


title: ss40 D4.P22


title: ss42 D6.P22


title: ss52 E4.P22


title: ss56 E8.P22


title: ss60 E12.P22


title: ss61 F1.P22


title: ss39 D3.P22


title: SS4 A4.P23


title: ss59 E11.P22


title: SS5 A5.P23


title: ss41 D5.P22


title: ss32 C8.P22


title: ss33 C9.P22


title: ss58 E10.P22


title: ss63 F3.P22


title: ss34 C10.P22


title: ss36 C12.P22


title: ss35 C11.P22


title: ss65 F5.P22


title: ss66 F6.P22


title: ss67 F7.P22


title: ss26 C2.P22


title: ss27 C3.P22


title: ss68 F8.P22


title: ss69 F9.P22


title: ss70 F10.P22


title: ss28 C4.P22


title: ss62 F2.P22


title: ss29 C5.P22


title: ss30 C6.P22


title: ss64 F4.P22


title: ss72 F12.P22


title: ss73 G1.P22


title: ss75 G3.P22


title: ss21 B9.P22


title: ss74 G2.P22


title: ss20 B8.P22


title: ss25 C1.P22


title: ss79 G7.P22


title: ss76 G4.P22


title: SS13 B1.P22


title: ss80 G8.P22


title: SS15 B3.P22


title: ss78 G6.P22


title: SS14 B2.P22


title: ss77 G5.P22


title: ss16 B4.P22


title: ss82 G10.P22


title: ss17 B5.P22


title: ss23 B11.P22


title: ss83 G11.P22


title: ss22 B10.P22


title: ss18 B6.P22


title: ss19 B7.P22


title: SS8 A8.P22


title: ss84 G12.P22


title: ss24 B12.P22


title: ss81 G9.P22


title: ss88 H4.P22


title: ss87 H3.P22


title: SS12 A12.P22


title: SS10 A10.P22


title: SS1 A1.P22


title: SS9 A9.P22


title: ss89 H5.P22


title: SS7 A7.P22


title: SS4 A4.P22


title: SS5 A5.P22


title: ss43 D7.P21

description:
CML_Plate1_PatNr.13_TKI
All patients included in this dataset responded well to TKI, but leukemic cells (Ph+) can still be detected in patient bone marrow.


title: SS3 A3.P22


title: SS2 A2.P22


title: SS6 A6.P22


title: ss91 H7.P22


title: ss49 E1.P21


title: SS11 A11.P22


title: ss92 H8.P22


title: ss44 D8.P21


title: ss50 E2.P21


title: ss90 H6.P22


title: ss31 C7.P22


title: ss45 D9.P21


title: ss51 E3.P21


title: ss47 D11.P21


title: ss46 D10.P21


title: ss52 E4.P21


title: ss54 E6.P21


title: ss55 E7.P21


title: ss38 D2.P21


title: ss37 D1.P21


title: ss56 E8.P21


title: ss57 E9.P21


title: ss41 D5.P21


title: ss60 E12.P21


title: ss58 E10.P21


title: ss40 D4.P21


title: ss61 F1.P21


title: ss62 F2.P21


title: ss32 C8.P21


title: ss42 D6.P21


title: ss35 C11.P21


title: ss34 C10.P21


title: ss36 C12.P21


title: ss48 D12.P21


title: ss33 C9.P21


title: ss66 F6.P21


title: ss67 F7.P21


title: ss26 C2.P21


title: ss68 F8.P21


title: ss70 F10.P21


title: ss71 F11.P21


title: ss30 C6.P21


title: ss28 C4.P21


title: ss69 F9.P21


title: ss72 F12.P21


title: ss31 C7.P21


title: ss19 B7.P21


title: ss59 E11.P21


title: ss20 B8.P21


title: ss74 G2.P21


title: ss22 B10.P21


title: ss76 G4.P21


title: ss21 B9.P21


title: ss23 B11.P21


title: ss27 C3.P21


title: ss24 B12.P21


title: ss77 G5.P21


title: ss78 G6.P21


title: ss73 G1.P21


title: SS13 B1.P21


title: ss79 G7.P21


title: ss81 G9.P21


title: SS14 B2.P21


title: ss82 G10.P21


title: ss83 G11.P21


title: SS15 B3.P21


title: ss18 B6.P21


title: ss16 B4.P21


title: ss84 G12.P21


title: ss17 B5.P21


title: ss87 H3.P21


title: SS9 A9.P21


title: ss88 H4.P21


title: SS7 A7.P21


title: ss89 H5.P21


title: SS12 A12.P21


title: ss90 H6.P21


title: SS1 A1.P21


title: ss91 H7.P21


title: SS4 A4.P21


title: SS3 A3.P21


title: ss43 D7.P20

description:
CML_Plate1_PatNr.13_Dx
All patients included in this dataset responded well to TKI, but leukemic cells (Ph+) can still be detected in patient bone marrow.


title: SS2 A2.P21


title: SS6 A6.P21


title: ss49 E1.P20


title: SS5 A5.P21


title: ss46 D10.P20


title: ss51 E3.P20


title: ss53 E5.P20


title: ss52 E4.P20


title: ss37 D1.P20


title: ss47 D11.P20


title: ss40 D4.P20


title: ss39 D3.P20


title: ss38 D2.P20


title: ss57 E9.P20


title: SS10 A10.P21


title: ss45 D9.P20


title: ss58 E10.P20


title: ss56 E8.P20


title: ss54 E6.P20


title: ss48 D12.P20


title: ss41 D5.P20


title: ss59 E11.P20


title: ss55 E7.P20


title: ss44 D8.P20


title: ss61 F1.P20


title: ss31 C7.P20


title: ss50 E2.P20


title: ss33 C9.P20


title: ss63 F3.P20


title: ss62 F2.P20


title: ss71 F11.P22


title: ss64 F4.P20


title: ss35 C11.P20


title: ss65 F5.P20


title: ss36 C12.P20


title: ss34 C10.P20


title: ss25 C1.P20


title: ss67 F7.P20


title: ss60 E12.P20


title: ss69 F9.P20


title: ss42 D6.P20


title: ss28 C4.P20


title: ss29 C5.P20


title: ss68 F8.P20


title: ss27 C3.P20


title: ss71 F11.P20


title: ss30 C6.P20


title: ss20 B8.P20


title: ss19 B7.P20


title: ss72 F12.P20


title: ss22 B10.P20


title: ss73 G1.P20


title: ss21 B9.P20


title: ss74 G2.P20


title: ss23 B11.P20


title: ss77 G5.P20


title: ss24 B12.P20


title: ss78 G6.P20


title: ss70 F10.P20


title: SS13 B1.P20


title: SS15 B3.P20


title: ss79 G7.P20


title: ss81 G9.P20


title: ss26 C2.P20


title: ss16 B4.P20


title: ss18 B6.P20


title: ss82 G10.P20


title: ss75 G3.P20


title: ss76 G4.P20


title: SS9 A9.P20


title: ss84 G12.P20


title: ss17 B5.P20


title: SS7 A7.P20


title: ss87 H3.P20


title: ss88 H4.P20


title: SS8 A8.P20


title: ss90 H6.P20


title: SS12 A12.P20


title: ss91 H7.P20


title: SS1 A1.P20


title: SS11 A11.P20


title: SS14 B2.P20


title: ss89 H5.P20


title: SS2 A2.P20


title: ss92 H8.P20


title: SS5 A5.P20


title: ss43 D7.P19

description:
nBM_PLate2_PatNr.4
All patients included in this dataset responded well to TKI, but leukemic cells (Ph+) can still be detected in patient bone marrow.

source_name: Normal Bone Marrow HSC

value: healthy control (nBM)

value: Normal Bone Marrow HSC


title: ss44 D8.P19


title: SS6 A6.P20


title: ss50 E2.P19


title: ss45 D9.P19


title: ss51 E3.P19


title: ss49 E1.P19


title: ss46 D10.P19


title: ss52 E4.P19


title: ss47 D11.P19


title: SS4 A4.P20


title: ss54 E6.P19


title: ss48 D12.P19


title: ss53 E5.P19


title: ss55 E7.P19


title: ss56 E8.P19


title: ss38 D2.P19


title: ss37 D1.P19


title: ss57 E9.P19


title: ss40 D4.P19


title: ss42 D6.P19


title: ss39 D3.P19


title: ss60 E12.P19


title: ss59 E11.P19


title: ss58 E10.P19


title: ss61 F1.P19


title: ss33 C9.P19


title: ss62 F2.P19


title: ss34 C10.P19


title: ss63 F3.P19


title: ss35 C11.P19


title: ss64 F4.P19


title: ss65 F5.P19


title: ss41 D5.P19


title: ss26 C2.P19


title: ss66 F6.P19


title: ss31 C7.P19


title: ss67 F7.P19


title: ss25 C1.P19


title: ss69 F9.P19


title: ss29 C5.P19


title: ss27 C3.P19


title: ss28 C4.P19


title: ss71 F11.P19


title: ss70 F10.P19


title: ss72 F12.P19


title: ss19 B7.P19


title: ss30 C6.P19


title: ss73 G1.P19


title: ss32 C8.P19


title: ss21 B9.P19


title: ss74 G2.P19


title: ss20 B8.P19


title: ss36 C12.P19


title: ss22 B10.P19


title: ss24 B12.P19


title: ss78 G6.P19


title: ss79 G7.P19


title: SS13 B1.P19


title: ss75 G3.P19


title: ss23 B11.P19


title: ss76 G4.P19


title: ss77 G5.P19


title: ss81 G9.P19


title: ss16 B4.P19


title: ss80 G8.P19


title: SS14 B2.P19


title: ss83 G11.P19


title: ss82 G10.P19


title: SS15 B3.P19


title: ss68 F8.P19


title: ss84 G12.P19


title: ss17 B5.P19


title: SS7 A7.P19


title: SS12 A12.P19


title: ss88 H4.P19


title: SS11 A11.P19


title: ss87 H3.P19


title: SS9 A9.P19


title: ss90 H6.P19


title: SS8 A8.P19


title: SS1 A1.P19


title: ss91 H7.P19


title: SS2 A2.P19


title: ss18 B6.P19


title: SS3 A3.P19


title: SS10 A10.P19


title: ss92 H8.P19


title: SS6 A6.P19


title: SS4 A4.P19


title: ss89 H5.P19


title: ss44 D8.P18

description:
CML_Plate1_PatNr.16_TKI
All patients included in this dataset responded well to TKI, but leukemic cells (Ph+) can still be detected in patient bone marrow.


title: ss49 E1.P18


title: ss46 D10.P18


title: ss52 E4.P18


title: ss45 D9.P18


title: ss50 E2.P18


title: ss48 D12.P18


title: ss54 E6.P18


title: ss37 D1.P18


title: ss51 E3.P18


title: ss55 E7.P18


title: ss40 D4.P18


title: ss39 D3.P18


title: ss58 E10.P18


title: ss38 D2.P18


title: ss41 D5.P18


title: ss56 E8.P18


title: ss59 E11.P18


title: SS5 A5.P19


title: ss42 D6.P18


title: ss31 C7.P18


title: ss32 C8.P18


title: ss65 F5.P18


title: ss33 C9.P18


title: ss25 C1.P18


title: ss57 E9.P18


title: ss36 C12.P18


title: ss68 F8.P18


title: ss66 F6.P18


title: ss27 C3.P18


title: ss70 F10.P18


title: ss67 F7.P18


title: ss29 C5.P18


title: ss28 C4.P18


title: ss71 F11.P18


title: ss62 F2.P18


title: ss30 C6.P18


title: ss60 E12.P18


title: ss74 G2.P18


title: ss72 F12.P18


title: ss19 B7.P18


title: ss77 G5.P18


title: ss24 B12.P18


title: ss23 B11.P18


title: ss76 G4.P18


title: ss78 G6.P18


title: ss73 G1.P18


title: ss69 F9.P18


title: ss79 G7.P18


title: SS14 B2.P18


title: ss21 B9.P18


title: ss81 G9.P18


title: ss26 C2.P18


title: SS15 B3.P18


title: ss80 G8.P18


title: ss18 B6.P18


title: ss16 B4.P18


title: ss82 G10.P18


title: ss84 G12.P18


title: ss17 B5.P18


title: SS8 A8.P18


title: SS7 A7.P18


title: ss89 H5.P18


title: SS11 A11.P18


title: ss83 G11.P18


title: ss88 H4.P18


title: SS10 A10.P18


title: ss91 H7.P18


title: SS1 A1.P18


title: SS13 B1.P18


title: SS3 A3.P18


title: SS2 A2.P18


title: SS4 A4.P18


title: ss92 H8.P18


title: SS5 A5.P18


title: ss49 E1.P17

description:
CML_Plate2_PatNr.16_Dx
All patients included in this dataset responded well to TKI, but leukemic cells (Ph+) can still be detected in patient bone marrow.


title: ss43 D7.P17


title: ss44 D8.P17


title: ss47 D11.P17


title: ss90 H6.P18


title: ss45 D9.P17


title: ss48 D12.P17


title: ss55 E7.P17


title: ss57 E9.P17


title: ss50 E2.P17


title: ss58 E10.P17


title: ss39 D3.P17


title: ss53 E5.P17


title: ss54 E6.P17


title: ss38 D2.P17


title: ss42 D6.P17


title: ss41 D5.P17


title: ss60 E12.P17


title: ss61 F1.P17


title: ss31 C7.P17


title: ss32 C8.P17


title: ss59 E11.P17


title: ss34 C10.P17


title: ss63 F3.P17


title: ss35 C11.P17


title: ss65 F5.P17


title: ss64 F4.P17


title: ss25 C1.P17


title: ss66 F6.P17


title: ss67 F7.P17


title: ss36 C12.P17


title: ss26 C2.P17


title: ss68 F8.P17


title: ss62 F2.P17


title: ss33 C9.P17


title: ss27 C3.P17


title: ss69 F9.P17


title: ss72 F12.P17


title: ss70 F10.P17


title: ss29 C5.P17


title: ss28 C4.P17


title: ss30 C6.P17


title: ss20 B8.P17


title: ss71 F11.P17


title: ss76 G4.P17


title: ss21 B9.P17


title: ss75 G3.P17


title: ss23 B11.P17


title: ss74 G2.P17


title: ss78 G6.P17


title: ss24 B12.P17


title: ss79 G7.P17


title: SS13 B1.P17


title: ss17 B5.P17


title: ss16 B4.P17


title: ss80 G8.P17


title: SS15 B3.P17


title: ss83 G11.P17


title: ss18 B6.P17


title: ss87 H3.P17


title: SS7 A7.P17


title: SS10 A10.P17


title: SS11 A11.P17


title: ss88 H4.P17


title: ss89 H5.P17


title: SS12 A12.P17


title: ss43 D7.P16

description:
CML_Plate1_PatNr.18_TKI
All patients included in this dataset responded well to TKI, but leukemic cells (Ph+) can still be detected in patient bone marrow.


title: ss92 H8.P17


title: ss90 H6.P17


title: SS2 A2.P17


title: ss50 E2.P16


title: ss44 D8.P16


title: ss46 D10.P16


title: ss49 E1.P16


title: ss47 D11.P16


title: ss48 D12.P16


title: ss37 D1.P16


title: ss38 D2.P16


title: ss55 E7.P16


title: ss56 E8.P16


title: ss39 D3.P16


title: SS3 A3.P17


title: ss54 E6.P16


title: SS4 A4.P17


title: SS5 A5.P17


title: ss57 E9.P16


title: ss40 D4.P16


title: SS6 A6.P17


title: ss58 E10.P16


title: ss41 D5.P16


title: ss91 H7.P17


title: ss51 E3.P16


title: ss59 E11.P16


title: ss60 E12.P16


title: ss31 C7.P16


title: ss42 D6.P16


title: ss53 E5.P16


title: ss52 E4.P16


title: ss32 C8.P16


title: ss33 C9.P16


title: ss45 D9.P16


title: ss34 C10.P16


title: ss63 F3.P16


title: ss64 F4.P16


title: ss35 C11.P16


title: ss65 F5.P16


title: ss36 C12.P16


title: ss68 F8.P16


title: ss70 F10.P16


title: ss28 C4.P16


title: ss25 C1.P16


title: ss69 F9.P16


title: ss61 F1.P16


title: ss27 C3.P16


title: ss29 C5.P16


title: ss71 F11.P16


title: ss62 F2.P16


title: ss30 C6.P16


title: ss26 C2.P16


title: ss67 F7.P16


title: ss19 B7.P16


title: ss73 G1.P16


title: ss72 F12.P16


title: ss74 G2.P16


title: ss21 B9.P16


title: ss20 B8.P16


title: ss75 G3.P16


title: ss23 B11.P16


title: ss24 B12.P16


title: ss66 F6.P16


title: ss78 G6.P16


title: ss77 G5.P16


title: ss79 G7.P16


title: SS13 B1.P16


title: SS14 B2.P16


title: SS15 B3.P16


title: ss83 G11.P16


title: ss18 B6.P16


title: ss84 G12.P16


title: ss17 B5.P16


title: ss82 G10.P16


title: ss22 B10.P16


title: SS8 A8.P16


title: ss16 B4.P16


title: ss81 G9.P16


title: SS7 A7.P16


title: SS9 A9.P16


title: ss87 H3.P16


title: SS10 A10.P16


title: ss76 G4.P16


title: SS11 A11.P16


title: ss88 H4.P16


title: ss90 H6.P16


title: SS12 A12.P16


title: ss91 H7.P16


title: SS2 A2.P16


title: ss92 H8.P16


title: SS3 A3.P16


title: SS4 A4.P16


title: ss80 G8.P16


title: SS5 A5.P16


title: SS6 A6.P16


title: ss43 D7.P15

description:
CML_Plate1_PatNr.15_Dx
All patients included in this dataset responded well to TKI, but leukemic cells (Ph+) can still be detected in patient bone marrow.


title: ss49 E1.P15


title: ss44 D8.P15


title: ss50 E2.P15


title: ss89 H5.P16


title: ss45 D9.P15


title: ss52 E4.P15


title: SS1 A1.P16


title: ss47 D11.P15


title: ss48 D12.P15


title: ss46 D10.P15


title: ss51 E3.P15


title: ss53 E5.P15


title: ss37 D1.P15


title: ss59 E11.P15


title: ss57 E9.P15


title: ss56 E8.P15


title: ss38 D2.P15


title: ss55 E7.P15


title: ss39 D3.P15


title: ss41 D5.P15


title: ss31 C7.P15


title: ss64 F4.P15


title: ss32 C8.P15


title: ss61 F1.P15


title: ss63 F3.P15


title: ss33 C9.P15


title: ss34 C10.P15


title: ss25 C1.P15


title: ss27 C3.P15


title: ss58 E10.P15


title: ss19 B7.P15


title: ss20 B8.P15


title: ss26 C2.P15


title: ss30 C6.P15


title: ss74 G2.P15


title: ss29 C5.P15


title: ss28 C4.P15


title: ss73 G1.P15


title: ss76 G4.P15


title: ss21 B9.P15


title: ss22 B10.P15


title: ss35 C11.P15


title: ss75 G3.P15


title: ss79 G7.P15


title: SS13 B1.P15


title: ss77 G5.P15


title: ss24 B12.P15


title: ss81 G9.P15


title: ss66 F6.P15


title: SS15 B3.P15


title: SS14 B2.P15


title: ss17 B5.P15


title: ss87 H3.P15


title: ss16 B4.P15


title: SS9 A9.P15


title: ss88 H4.P15


title: SS11 A11.P15


title: SS10 A10.P15


title: ss78 G6.P15


title: SS12 A12.P15


title: SS1 A1.P15


title: ss90 H6.P15


title: SS2 A2.P15


title: ss91 H7.P15


title: SS3 A3.P15


title: ss92 H8.P15


title: ss 93 H9.P15


title: SS4 A4.P15


title: SS8 A8.P15


title: ss94 H10.P15


title: ss95 H11.P15


title: SS6 A6.P15


title: ss44 D8.P14

description:
CML_Plate1_PatNr.17_Dx_PB
All patients included in this dataset responded well to TKI, but leukemic cells (Ph+) can still be detected in patient bone marrow.


title: ss50 E2.P14


title: ss48 D12.P14


title: ss46 D10.P14


title: ss47 D11.P14


title: ss52 E4.P14


title: ss45 D9.P14


title: ss51 E3.P14


title: ss54 E6.P14


title: ss43 D7.P14


title: ss37 D1.P14


title: ss53 E5.P14


title: ss39 D3.P14


title: ss56 E8.P14


title: ss38 D2.P14


title: ss57 E9.P14


title: ss40 D4.P14


title: ss55 E7.P14


title: ss31 C7.P14


title: ss41 D5.P14


title: ss32 C8.P14


title: ss33 C9.P14


title: ss62 F2.P14


title: ss64 F4.P14


title: ss34 C10.P14


title: ss35 C11.P14


title: ss65 F5.P14


title: ss36 C12.P14


title: ss59 E11.P14


title: ss69 F9.P14


title: ss28 C4.P14


title: ss27 C3.P14


title: ss68 F8.P14


title: ss63 F3.P14


title: ss26 C2.P14


title: ss58 E10.P14


title: ss67 F7.P14


title: ss29 C5.P14


title: ss70 F10.P14


title: ss25 C1.P14


title: ss66 F6.P14


title: ss71 F11.P14


title: ss30 C6.P14


title: ss73 G1.P14


title: ss20 B8.P14


title: ss21 B9.P14


title: ss74 G2.P14


title: ss61 F1.P14


title: ss75 G3.P14


title: ss22 B10.P14


title: ss76 G4.P14


title: ss77 G5.P14


title: SS13 B1.P14


title: SS15 B3.P14


title: ss24 B12.P14


title: ss80 G8.P14


title: ss81 G9.P14


title: ss17 B5.P14


title: ss78 G6.P14


title: ss23 B11.P14


title: SS7 A7.P14


title: ss87 H3.P14


title: ss16 B4.P14


title: SS8 A8.P14


title: ss88 H4.P14


title: ss79 G7.P14


title: ss89 H5.P14


title: SS12 A12.P14


title: SS10 A10.P14


title: ss91 H7.P14


title: SS1 A1.P14


title: SS2 A2.P14


title: ss83 G11.P14


title: ss18 B6.P14


title: SS4 A4.P14


title: SS9 A9.P14


title: ss82 G10.P14


title: ss92 H8.P14


title: ss94 H10.P14


title: ss95 H11.P14


title: SS3 A3.P14


title: SS5 A5.P14


title: ss46 D10.P13

description:
CML_Plate2_PatNr.17_TKI
All patients included in this dataset responded well to TKI, but leukemic cells (Ph+) can still be detected in patient bone marrow.


title: ss90 H6.P14


title: ss44 D8.P13


title: ss45 D9.P13


title: ss43 D7.P13


title: ss50 E2.P13


title: SS6 A6.P14


title: ss47 D11.P13


title: ss51 E3.P13


title: ss53 E5.P13


title: ss37 D1.P13


title: ss52 E4.P13


title: ss55 E7.P13


title: ss54 E6.P13


title: ss48 D12.P13


title: ss38 D2.P13


title: ss39 D3.P13


title: ss57 E9.P13


title: ss56 E8.P13


title: ss40 D4.P13


title: ss41 D5.P13


title: ss49 E1.P13


title: ss42 D6.P13


title: ss60 E12.P13


title: ss31 C7.P13


title: ss32 C8.P13


title: ss64 F4.P13


title: ss62 F2.P13


title: ss35 C11.P13


title: ss36 C12.P13


title: ss34 C10.P13


title: ss63 F3.P13


title: ss33 C9.P13


title: ss65 F5.P13


title: ss66 F6.P13


title: ss68 F8.P13


title: ss67 F7.P13


title: ss59 E11.P13


title: ss69 F9.P13


title: ss26 C2.P13


title: ss25 C1.P13


title: ss27 C3.P13


title: ss28 C4.P13


title: ss71 F11.P13


title: ss30 C6.P13


title: ss72 F12.P13


title: ss20 B8.P13


title: ss73 G1.P13


title: ss61 F1.P13


title: ss19 B7.P13


title: ss29 C5.P13


title: ss74 G2.P13


title: ss21 B9.P13


title: ss22 B10.P13


title: ss75 G3.P13


title: ss77 G5.P13


title: ss76 G4.P13


title: ss24 B12.P13


title: ss78 G6.P13


title: SS13 B1.P13


title: ss80 G8.P13


title: ss79 G7.P13


title: SS14 B2.P13


title: ss17 B5.P13


title: ss82 G10.P13


title: SS15 B3.P13


title: ss23 B11.P13


title: ss18 B6.P13


title: ss83 G11.P13


title: ss16 B4.P13


title: ss84 G12.P13


title: SS9 A9.P13


title: SS10 A10.P13


title: SS8 A8.P13


title: SS11 A11.P13


title: ss87 H3.P13


title: ss88 H4.P13


title: SS12 A12.P13


title: ss91 H7.P13


title: ss90 H6.P13


title: ss89 H5.P13


title: SS3 A3.P13


title: SS1 A1.P13


title: ss92 H8.P13


title: ss81 G9.P13


title: SS2 A2.P13


title: SS5 A5.P13


title: SS4 A4.P13


title: ss49 E1.P12

description:
CML_Plate2_PatNr.15_TKI
All patients included in this dataset responded well to TKI, but leukemic cells (Ph+) can still be detected in patient bone marrow.


title: ss44 D8.P12


title: ss50 E2.P12


title: ss51 E3.P12


title: ss46 D10.P12


title: ss52 E4.P12


title: ss53 E5.P12


title: ss47 D11.P12


title: ss37 D1.P12


title: ss55 E7.P12


title: ss57 E9.P12


title: ss56 E8.P12


title: ss38 D2.P12


title: ss58 E10.P12


title: ss39 D3.P12


title: ss59 E11.P12


title: ss41 D5.P12


title: SS6 A6.P13


title: ss42 D6.P12


title: ss31 C7.P12


title: ss45 D9.P12


title: ss60 E12.P12


title: ss48 D12.P12


title: ss40 D4.P12


title: ss32 C8.P12


title: ss54 E6.P12


title: ss63 F3.P12


title: ss62 F2.P12


title: ss35 C11.P12


title: ss34 C10.P12


title: ss65 F5.P12


title: ss25 C1.P12


title: ss66 F6.P12


title: ss36 C12.P12


title: ss28 C4.P12


title: ss68 F8.P12


title: ss67 F7.P12


title: ss71 F11.P12


title: ss70 F10.P12


title: ss29 C5.P12


title: ss27 C3.P12


title: ss69 F9.P12


title: ss30 C6.P12


title: ss72 F12.P12


title: ss33 C9.P12


title: ss19 B7.P12


title: ss64 F4.P12


title: ss73 G1.P12


title: ss20 B8.P12


title: ss21 B9.P12


title: ss61 F1.P12


title: ss22 B10.P12


title: ss75 G3.P12


title: ss26 C2.P12


title: ss76 G4.P12


title: ss23 B11.P12


title: ss77 G5.P12


title: ss24 B12.P12


title: ss78 G6.P12


title: ss79 G7.P12


title: SS14 B2.P12


title: SS13 B1.P12


title: ss17 B5.P12


title: ss82 G10.P12


title: ss83 G11.P12


title: ss74 G2.P12


title: ss18 B6.P12


title: SS7 A7.P12


title: SS10 A10.P12


title: SS8 A8.P12


title: ss87 H3.P12


title: SS9 A9.P12


title: ss90 H6.P12


title: SS11 A11.P12


title: ss88 H4.P12


title: SS12 A12.P12


title: SS1 A1.P12


title: ss91 H7.P12


title: SS2 A2.P12


title: ss92 H8.P12


title: SS5 A5.P12


title: SS4 A4.P12


title: ss16 B4.P12


title: SS6 A6.P12


title: SS3 A3.P12


title: ss43 D7.P11

description:
CML_Plate1_PatNr.16_Dx
All patients included in this dataset responded well to TKI, but leukemic cells (Ph+) can still be detected in patient bone marrow.


title: ss84 G12.P12


title: ss81 G9.P12


title: ss80 G8.P12


title: SS15 B3.P12


title: ss44 D8.P11


title: ss51 E3.P11


title: ss46 D10.P11


title: ss52 E4.P11


title: ss47 D11.P11


title: ss45 D9.P11


title: ss53 E5.P11


title: ss48 D12.P11


title: ss54 E6.P11


title: ss37 D1.P11


title: ss55 E7.P11


title: ss50 E2.P11


title: ss39 D3.P11


title: ss56 E8.P11


title: ss59 E11.P11


title: ss57 E9.P11


title: ss42 D6.P11


title: ss41 D5.P11


title: ss38 D2.P11


title: ss40 D4.P11


title: ss60 E12.P11


title: ss61 F1.P11


title: ss62 F2.P11


title: ss25 C1.P11


title: ss36 C12.P11


title: ss63 F3.P11


title: ss34 C10.P11


title: ss67 F7.P11


title: ss35 C11.P11


title: ss26 C2.P11


title: ss64 F4.P11


title: ss68 F8.P11


title: ss69 F9.P11


title: ss29 C5.P11


title: ss28 C4.P11


title: ss30 C6.P11


title: ss70 F10.P11


title: ss31 C7.P11


title: ss21 B9.P11


title: ss72 F12.P11


title: ss74 G2.P11


title: ss33 C9.P11


title: SS14 B2.P11


title: ss23 B11.P11


title: ss76 G4.P11


title: ss22 B10.P11


title: ss78 G6.P11


title: ss24 B12.P11


title: SS15 B3.P11


title: ss27 C3.P11


title: ss79 G7.P11


title: SS13 B1.P11


title: ss80 G8.P11


title: ss17 B5.P11


title: ss83 G11.P11


title: SS8 A8.P11


title: ss77 G5.P11


title: ss87 H3.P11


title: SS7 A7.P11


title: SS11 A11.P11


title: SS12 A12.P11


title: ss90 H6.P11


title: ss75 G3.P11


title: SS2 A2.P11


title: ss81 G9.P11


title: ss92 H8.P11


title: SS1 A1.P11


title: ss48 D12.P10

description:
CML_Plate2_PatNr.16_TKI
All patients included in this dataset responded well to TKI, but leukemic cells (Ph+) can still be detected in patient bone marrow.


title: ss18 B6.P11


title: SS9 A9.P11


title: ss51 E3.P10


title: ss50 E2.P10


title: ss37 D1.P10


title: ss43 D7.P10


title: SS4 A4.P11


title: ss57 E9.P10


title: ss44 D8.P10


title: ss49 E1.P10


title: ss56 E8.P10


title: SS6 A6.P11


title: ss55 E7.P10


title: ss40 D4.P10


title: ss45 D9.P10


title: ss47 D11.P10


title: ss52 E4.P10


title: SS3 A3.P11


title: ss42 D6.P10


title: ss46 D10.P10


title: ss59 E11.P10


title: ss41 D5.P10


title: ss58 E10.P10


title: ss31 C7.P10


title: ss60 E12.P10


title: ss32 C8.P10


title: ss33 C9.P10


title: ss62 F2.P10


title: ss35 C11.P10


title: ss34 C10.P10


title: ss65 F5.P10


title: ss36 C12.P10


title: ss63 F3.P10


title: ss27 C3.P10


title: ss26 C2.P10


title: ss28 C4.P10


title: ss67 F7.P10


title: ss69 F9.P10


title: ss25 C1.P10


title: ss66 F6.P10


title: ss71 F11.P10


title: ss70 F10.P10


title: ss30 C6.P10


title: ss19 B7.P10


title: ss29 C5.P10


title: ss73 G1.P10


title: ss72 F12.P10


title: ss74 G2.P10


title: ss20 B8.P10


title: ss75 G3.P10


title: ss22 B10.P10


title: ss21 B9.P10


title: ss77 G5.P10


title: ss24 B12.P10


title: ss79 G7.P10


title: ss76 G4.P10


title: ss78 G6.P10


title: SS15 B3.P10


title: SS5 A5.P11


title: ss17 B5.P10


title: ss81 G9.P10


title: SS14 B2.P10


title: ss16 B4.P10


title: ss18 B6.P10


title: SS7 A7.P10


title: SS9 A9.P10


title: ss87 H3.P10


title: SS8 A8.P10


title: ss88 H4.P10


title: ss23 B11.P10


title: ss89 H5.P10


title: SS10 A10.P10


title: ss82 G10.P10


title: SS12 A12.P10


title: ss90 H6.P10


title: SS11 A11.P10


title: SS13 B1.P10


title: ss88 H4.P11


title: SS1 A1.P10


title: SS2 A2.P10


title: ss92 H8.P10


title: SS3 A3.P10


title: SS5 A5.P10


title: SS6 A6.P10


title: ss50 E2.P9

description:
CML_Plate4_PatNr.14_TKI
All patients included in this dataset responded well to TKI, but leukemic cells (Ph+) can still be detected in patient bone marrow.


title: ss45 D9.P9


title: ss43 D7.P9


title: ss46 D10.P9


title: ss53 E5.P9


title: ss44 D8.P9


title: ss55 E7.P9


title: ss38 D2.P9


title: ss48 D12.P9


title: ss47 D11.P9


title: ss37 D1.P9


title: ss54 E6.P9


title: ss39 D3.P9


title: ss56 E8.P9


title: ss58 E10.P9


title: ss91 H7.P10


title: ss40 D4.P9


title: ss57 E9.P9


title: ss52 E4.P9


title: ss51 E3.P9


title: ss49 E1.P9


title: ss59 E11.P9


title: ss60 E12.P9


title: ss42 D6.P9


title: SS4 A4.P10


title: ss61 F1.P9


title: ss32 C8.P9


title: ss33 C9.P9


title: ss31 C7.P9


title: ss35 C11.P9


title: ss41 D5.P9


title: ss36 C12.P9


title: ss26 C2.P9


title: ss70 F10.P9


title: ss62 F2.P9


title: ss67 F7.P9


title: ss64 F4.P9


title: ss65 F5.P9


title: ss63 F3.P9


title: ss34 C10.P9


title: ss66 F6.P9


title: ss25 C1.P9


title: ss69 F9.P9


title: ss73 G1.P9


title: ss71 F11.P9


title: ss28 C4.P9


title: ss39 D3.P10


title: ss68 F8.P9


title: ss27 C3.P9


title: ss29 C5.P9


title: ss22 B10.P9


title: ss20 B8.P9


title: ss21 B9.P9


title: ss23 B11.P9


title: ss30 C6.P9


title: ss24 B12.P9


title: ss76 G4.P9


title: ss19 B7.P9


title: ss72 F12.P9


title: ss77 G5.P9


title: ss78 G6.P9


title: ss75 G3.P9


title: ss79 G7.P9


title: SS15 B3.P9


title: ss80 G8.P9


title: ss81 G9.P9


title: ss17 B5.P9


title: ss16 B4.P9


title: ss83 G11.P9


title: SS14 B2.P9


title: ss18 B6.P9


title: ss74 G2.P9


title: ss87 H3.P9


title: SS10 A10.P9


title: SS8 A8.P9


title: ss84 G12.P9


title: SS9 A9.P9


title: ss82 G10.P9


title: ss88 H4.P9


title: ss89 H5.P9


title: SS13 B1.P9


title: ss90 H6.P9


title: SS1 A1.P9


title: ss91 H7.P9


title: SS12 A12.P9


title: SS3 A3.P9


title: SS2 A2.P9


title: SS4 A4.P9


title: SS7 A7.P9


title: SS5 A5.P9


title: SS6 A6.P9


title: ss50 E2.P8

description:
CML_Plate1_PatNr.14_Dx
All patients included in this dataset responded well to TKI, but leukemic cells (Ph+) can still be detected in patient bone marrow.


title: ss44 D8.P8


title: ss45 D9.P8


title: ss46 D10.P8


title: SS11 A11.P9


title: ss43 D7.P8


title: ss49 E1.P8


title: ss37 D1.P8


title: ss54 E6.P8


title: ss47 D11.P8


title: ss55 E7.P8


title: ss52 E4.P8


title: ss92 H8.P9


title: ss56 E8.P8


title: ss39 D3.P8


title: ss57 E9.P8


title: ss40 D4.P8


title: ss41 D5.P8


title: ss58 E10.P8


title: ss42 D6.P8


title: ss59 E11.P8


title: ss51 E3.P8


title: ss33 C9.P8


title: ss63 F3.P8


title: ss32 C8.P8


title: ss31 C7.P8


title: ss61 F1.P8


title: ss64 F4.P8


title: ss48 D12.P8


title: ss62 F2.P8


title: ss53 E5.P8


title: ss36 C12.P8


title: ss35 C11.P8


title: ss65 F5.P8


title: ss68 F8.P8


title: ss66 F6.P8


title: ss67 F7.P8


title: ss26 C2.P8


title: ss25 C1.P8


title: ss60 E12.P8


title: ss28 C4.P8


title: ss69 F9.P8


title: ss70 F10.P8


title: ss27 C3.P8


title: ss30 C6.P8


title: ss34 C10.P8


title: ss72 F12.P8


title: ss73 G1.P8


title: ss20 B8.P8


title: ss74 G2.P8


title: ss23 B11.P8


title: ss77 G5.P8


title: ss24 B12.P8


title: ss19 B7.P8


title: SS15 B3.P8


title: SS14 B2.P8


title: ss80 G8.P8


title: ss78 G6.P8


title: ss79 G7.P8


title: ss29 C5.P8


title: SS13 B1.P8


title: ss82 G10.P8


title: ss16 B4.P8


title: ss71 F11.P8


title: ss81 G9.P8


title: ss84 G12.P8


title: ss18 B6.P8


title: SS7 A7.P8


title: ss17 B5.P8


title: ss76 G4.P8


title: ss22 B10.P8


title: SS8 A8.P8


title: ss75 G3.P8


title: ss87 H3.P8


title: ss83 G11.P8


title: SS9 A9.P8


title: SS11 A11.P8


title: ss89 H5.P8


title: SS10 A10.P8


title: SS12 A12.P8


title: ss90 H6.P8


title: ss88 H4.P8


title: SS3 A3.P8


title: SS4 A4.P8


title: ss91 H7.P8


title: ss54 E6.P7

description:
CML_Plate3_PatNr.7_Dx
All patients included in this dataset responded well to TKI, but leukemic cells (Ph+) can still be detected in patient bone marrow.


title: SS1 A1.P8


title: SS5 A5.P8


title: ss48 D12.P7


title: SS6 A6.P8


title: SS2 A2.P8


title: ss92 H8.P8


title: ss45 D9.P7


title: ss47 D11.P7


title: ss46 D10.P7


title: ss52 E4.P7


title: ss50 E2.P7


title: ss49 E1.P7


title: ss43 D7.P7


title: ss44 D8.P7


title: ss60 E12.P7


title: ss59 E11.P7


title: ss58 E10.P7


title: ss57 E9.P7


title: ss51 E3.P7


title: ss53 E5.P7


title: ss40 D4.P7


title: ss39 D3.P7


title: ss55 E7.P7


title: ss56 E8.P7


title: ss37 D1.P7


title: ss36 C12.P7


title: ss21 B9.P8


title: ss35 C11.P7


title: ss34 C10.P7


title: ss62 F2.P7


title: ss33 C9.P7


title: ss31 C7.P7


title: ss42 D6.P7


title: ss61 F1.P7


title: ss70 F10.P7


title: ss30 C6.P7


title: ss71 F11.P7


title: ss29 C5.P7


title: ss68 F8.P7


title: ss67 F7.P7


title: ss78 G6.P7


title: ss38 D2.P7


title: ss24 B12.P7


title: ss65 F5.P7


title: ss26 C2.P7


title: ss77 G5.P7


title: ss32 C8.P7


title: ss76 G4.P7


title: ss22 B10.P7


title: ss21 B9.P7


title: ss74 G2.P7


title: ss20 B8.P7


title: ss19 B7.P7


title: ss25 C1.P7


title: ss18 B6.P7


title: ss73 G1.P7


title: ss83 G11.P7


title: ss17 B5.P7


title: ss72 F12.P7


title: ss81 G9.P7


title: ss16 B4.P7


title: ss82 G10.P7


title: ss14 B2.P7


title: ss23 B11.P7


title: ss75 G3.P7


title: ss88 H6.P7


title: ss79 G7.P7


title: ss11 A11.P7


title: ss84 G12.P7


title: ss85 H3.P7


title: ss12 A12.P7


title: ss86 H4.P7


title: ss13 B1.P7


title: ss87 H5.P7


title: ss84 20.P7


title: ss9 A9.P7


title: ss83 10.P7


title: ss7 A7.P7


title: ss8 A8.P7


title: ss5 A5.P7


title: ss6 A6.P7


title: ss89 H7.P7


title: ss2 A2.P7


title: ss4 A4.P7


title: ss3 A3.P7


title: ss1 A1.P7


title: ss10 A10.P7


title: ss90 H8.P7


title: ss44 D8.P6

description:
CML_Plate1_PatNr.8_TKI
All patients included in this dataset responded well to TKI, but leukemic cells (Ph+) can still be detected in patient bone marrow.


title: ss50 E2.P6


title: ss43 D7.P6


title: ss49 E1.P6


title: ss46 D10.P6


title: ss47 D11.P6


title: ss54 E6.P6


title: ss45 D9.P6


title: ss53 E5.P6


title: ss52 E4.P6


title: ss51 E3.P6


title: ss48 D12.P6


title: ss39 D3.P6


title: ss56 E8.P6


title: ss38 D2.P6


title: ss55 E7.P6


title: ss37 D1.P6


title: ss57 E9.P6


title: ss42 D6.P6


title: ss31 C7.P6


title: ss60 E12.P6


title: ss58 E10.P6


title: ss41 D5.P6


title: ss61 F1.P6


title: ss32 C8.P6


title: ss62 F2.P6


title: ss33 C9.P6


title: ss63 F3.P6


title: ss66 F6.P6


title: ss68 F8.P6


title: ss65 F5.P6


title: ss35 C11.P6


title: ss64 F4.P6


title: ss25 C1.P6


title: ss34 C10.P6


title: ss26 C2.P6


title: ss40 D4.P6


title: ss36 C12.P6


title: ss27 C3.P6


title: ss71 F11.P6


title: ss28 C4.P6


title: ss70 F10.P6


title: ss29 C5.P6


title: ss69 F9.P6


title: ss59 E11.P6


title: ss16 B4.P11


title: ss30 C6.P6


title: ss67 F7.P6


title: ss19 B7.P6


title: ss72 F12.P6


title: ss21 B9.P6


title: ss20 B8.P6


title: ss74 G2.P6


title: ss73 G1.P6


title: ss75 G3.P6


title: ss76 G4.P6


title: ss77 G5.P6


title: ss22 B10.P6


title: ss81 G9.P6


title: ss78 G6.P6


title: ss80 G8.P6


title: ss79 G7.P6


title: SS14 B2.P6


title: SS15 B3.P6


title: SS8 A8.P6


title: ss82 G10.P6


title: ss17 B5.P6


title: ss84 G12.P6


title: SS13 B1.P6


title: ss18 B6.P6


title: SS9 A9.P6


title: SS10 A10.P6


title: ss23 B11.P6


title: ss88 H4.P6


title: ss24 B12.P6


title: ss16 B4.P6


title: SS11 A11.P6


title: SS12 A12.P6


title: ss89 H5.P6


title: SS3 A3.P6


title: ss92 H8.P6


title: SS1 A1.P6


title: ss91 H7.P6


title: SS2 A2.P6


title: SS4 A4.P6


title: ss83 G11.P6


title: SS5 A5.P6


title: SS6 A6.P6


title: ss43 D7.P5

description:
nBM_PLate1_PatNr.4
All patients included in this dataset responded well to TKI, but leukemic cells (Ph+) can still be detected in patient bone marrow.


title: ss49 E1.P5


title: ss50 E2.P5


title: ss44 D8.P5


title: ss52 E4.P5


title: ss55 E7.P5


title: ss38 D2.P5


title: ss46 D10.P5


title: ss51 E3.P5


title: ss45 D9.P5


title: ss54 E6.P5


title: ss48 D12.P5


title: ss37 D1.P5


title: ss39 D3.P5


title: ss53 E5.P5


title: ss47 D11.P5


title: ss61 F1.P5


title: ss31 C7.P5


title: ss42 D6.P5


title: ss57 E9.P5


title: ss40 D4.P5


title: ss32 C8.P5


title: ss41 D5.P5


title: ss58 E10.P5


title: ss56 E8.P5


title: ss59 E11.P5


title: ss33 C9.P5


title: ss62 F2.P5


title: ss64 F4.P5


title: ss63 F3.P5


title: ss34 C10.P5


title: ss26 C2.P5


title: ss35 C11.P5


title: ss68 F8.P5


title: ss27 C3.P5


title: ss25 C1.P5


title: ss66 F6.P5


title: ss71 F11.P5


title: ss67 F7.P5


title: ss29 C5.P5


title: ss36 C12.P5


title: ss69 F9.P5


title: ss76 G4.P5


title: ss75 G3.P5


title: ss21 B9.P5


title: ss30 C6.P5


title: ss19 B7.P5


title: ss24 B12.P5


title: ss23 B11.P5


title: ss28 C4.P5


title: SS14 B2.P5


title: ss70 F10.P5


title: ss73 G1.P5


title: ss22 B10.P5


title: ss74 G2.P5


title: ss65 F5.P5


title: ss77 G5.P5


title: ss20 B8.P5


title: SS13 B1.P5


title: ss78 G6.P5


title: SS7 A7.P5


title: ss16 B4.P5


title: ss81 G9.P5


title: SS12 A12.P5


title: ss17 B5.P5


title: ss88 H4.P5


title: ss87 H3.P5


title: SS15 B3.P5


title: ss80 G8.P5


title: ss82 G10.P5


title: ss18 B6.P5


title: ss83 G11.P5


title: ss91 H7.P5


title: ss79 G7.P5


title: SS3 A3.P5


title: SS9 A9.P5


title: SS11 A11.P5


title: SS10 A10.P5


title: ss89 H5.P5


title: ss90 H6.P5


title: SS1 A1.P5


title: ss43 D7.P4

description:
CML_Plate1_PatNr.8_Dx
All patients included in this dataset responded well to TKI, but leukemic cells (Ph+) can still be detected in patient bone marrow.


title: SS2 A2.P5


title: ss92 H8.P5


title: ss49 E1.P4


title: ss46 D10.P4


title: SS8 A8.P5


title: ss 93 noRT H9.P5


title: ss51 E3.P4


title: SS4 A4.P5


title: SS5 A5.P5


title: ss94noRT H10.P5


title: ss95noRT H11.P5


title: ss57 E9.P4


title: ss39 D3.P4


title: SS6 A6.P5


title: ss59 E11.P4


title: ss44 D8.P4


title: ss50 E2.P4


title: ss45 D9.P4


title: ss42 D6.P4


title: ss47 D11.P4


title: ss52 E4.P4


title: ss61 F1.P4


title: ss48 D12.P4


title: ss53 E5.P4


title: ss63 F3.P4


title: ss34 C10.P4


title: ss40 D4.P4


title: ss37 D1.P4


title: ss35 C11.P4


title: ss55 E7.P4


title: ss65 F5.P4


title: ss38 D2.P4


title: ss54 E6.P4


title: ss41 D5.P4


title: ss60 E12.P4


title: ss31 C7.P4


title: ss32 C8.P4


title: ss29 C5.P4


title: ss30 C6.P4


title: ss72 F12.P4


title: ss62 F2.P4


title: ss28 C4.P4


title: ss70 F10.P4


title: ss68 F8.P4


title: ss19 B7.P4


title: ss27 C3.P4


title: ss33 C9.P4


title: ss64 F4.P4


title: ss22 B10.P4


title: ss58 E10.P4


title: ss36 C12.P4


title: ss66 F6.P4


title: ss23 B11.P4


title: ss69 F9.P4


title: ss71 F11.P4


title: ss67 F7.P4


title: ss25 C1.P4


title: SS13 B1.P4


title: ss79 G7.P4


title: SS14 B2.P4


title: ss82 G10.P4


title: ss75 G3.P4


title: ss74 G2.P4


title: ss20 B8.P4


title: ss73 G1.P4


title: ss21 B9.P4


title: ss78 G6.P4


title: ss26 C2.P4


title: SS10 A10.P4


title: SS8 A8.P4


title: ss76 G4.P4


title: ss88 H4.P4


title: ss90 H6.P4


title: ss77 G5.P4


title: ss24 B12.P4


title: ss80 G8.P4


title: ss81 G9.P4


title: ss16 B4.P4


title: SS15 B3.P4


title: SS4 A4.P4


title: ss83 G11.P4


title: ss84 G12.P4


title: ss18 B6.P4


title: SS12 A12.P4


title: SS9 A9.P4


title: ss87 H3.P4


title: SS11 A11.P4


title: ss89 H5.P4


title: SS7 A7.P4


title: ss91 H7.P4


title: SS1 A1.P4


title: ss17 B5.P4


title: SS2 A2.P4


title: ss92 H8.P4


title: ss38 D2 D.P3

description:
CML_Plate1_PatNr.19_Dx
All patients included in this dataset responded well to TKI, but leukemic cells (Ph+) can still be detected in patient bone marrow.


title: ss39 D3 D.P3


title: ss57 E9 TKI.P3

description:
CML_Plate1_PatNr.19_TKI
All patients included in this dataset responded well to TKI, but leukemic cells (Ph+) can still be detected in patient bone marrow.


title: SS3 A3.P4


title: SS5 A5.P4


title: ss43 D7 TKI.P3


title: SS6 A6.P4


title: ss51 E3 D.P3


title: ss58 E10 TKI.P3


title: ss45 D9 TKI.P3


title: ss47 D11 TKI.P3


title: ss46 D10 TKI.P3


title: ss61 F1 D.P3


title: ss31 C7 TKI.P3


title: ss32 C8 TKI.P3


title: ss33 C9 TKI.P3


title: ss48 D12 TKI.P3


title: ss55 E7 TKI.P3


title: ss53 E5 D.P3


title: ss44 D8 TKI.P3


title: ss50 E2 D.P3


title: ss41 D5 D.P3


title: ss40 D4 D.P3


title: ss67 F7 TKI.P3


title: ss34 C10 TKI.P3


title: ss56 E8 TKI.P3


title: ss69 F9 TKI.P3


title: ss62 F2 D.P3


title: ss64 F4 D.P3


title: ss26 C2 D.P3


title: ss71 F11 TKI.P3


title: ss35 C11 TKI.P3


title: ss25 C1 D.P3


title: ss21 B9 TKI.P3


title: ss19 B7 TKI.P3


title: ss74 G2 D.P3


title: ss68 F8 TKI.P3


title: ss59 E11 TKI.P3


title: ss76 G4 D.P3


title: ss77 G5 D.P3


title: ss23 B11 TKI.P3


title: ss70 F10 TKI.P3


title: ss22 B10 TKI.P3


title: ss65 F5 D.P3


title: ss79 G7 TKI.P3


title: SS15 B3 D.P3


title: ss24 B12 TKI.P3


title: ss30 C6 D.P3


title: SS14 B2 D.P3


title: ss75 G3 D.P3


title: ss82 G10 TKI.P3


title: ss29 C5 D.P3


title: ss83 G11 TKI.P3


title: ss18 B6 D.P3


title: ss80 G8 TKI.P3


title: SS7 A7 TKI.P3


title: SS8 A8 TKI.P3


title: ss87 H3 D.P3


title: SS10 A10 TKI.P3


title: SS11 A11 TKI.P3


title: ss89 H5 D.P3


title: ss90 H6 D.P3


title: SS3 A3 D.P3


title: ss94 H10 TKI.P3


title: ss 93 H9 TKI.P3


title: SS9 A9 TKI.P3


title: ss49 E1.P2

description:
CML_Plate1_PatNr.6_Dx
All patients included in this dataset responded well to TKI, but leukemic cells (Ph+) can still be detected in patient bone marrow.


title: SS6 A6 D.P3


title: SS5 A5 D.P3


title: ss44 D8.P2


title: ss43 D7.P2


title: ss17 B5 D.P3


title: ss50 E2.P2


title: ss52 E4.P2


title: ss95 H11 TKI.P3


title: ss47 D11.P2


title: ss46 D10.P2


title: ss51 E3.P2


title: ss53 E5.P2


title: ss56 E8.P2


title: ss48 D12.P2


title: ss54 E6.P2


title: ss38 D2.P2


title: ss59 E11.P2


title: SS1 A1 D.P3


title: ss39 D3.P2


title: ss40 D4.P2


title: ss61 F1.P2


title: ss31 C7.P2


title: ss42 D6.P2


title: ss32 C8.P2


title: ss60 E12.P2


title: ss35 C11.P2


title: ss36 C12.P2


title: ss67 F7.P2


title: ss62 F2.P2


title: ss26 C2.P2


title: ss63 F3.P2


title: ss34 C10.P2


title: ss64 F4.P2


title: ss69 F9.P2


title: ss25 C1.P2


title: ss66 F6.P2


title: ss58 E10.P2


title: ss68 F8.P2


title: ss71 F11.P2


title: ss30 C6.P2


title: ss20 B8.P2


title: ss76 G4.P2


title: ss28 C4.P2


title: ss33 C9.P2


title: ss72 F12.P2


title: ss78 G6.P2


title: ss27 C3.P2


title: ss29 C5.P2


title: ss70 F10.P2


title: ss73 G1.P2


title: ss79 G7.P2


title: ss74 G2.P2


title: ss21 B9.P2


title: SS13 B1.P2


title: ss23 B11.P2


title: SS15 B3.P2


title: ss24 B12.P2


title: SS8 A8.P2


title: ss82 G10.P2


title: ss87 H3.P2


title: SS14 B2.P2


title: ss18 B6.P2


title: SS10 A10.P2


title: ss80 G8.P2


title: SS11 A11.P2


title: SS1 A1.P2


title: Skin Inverse Psoriasis 40

city: Ann Arbor

first: Andrew

last: Johnston

state: Michigan

address: 1301 East Catherine Street

department: Dermatology

institute: University of Michigan

hyb_protocol: Following Labeling procedure, 2.5 ug of cDNA were hybridized at 48C on Human Gene ST 2.1 arrays, and were washed and stained using the Affymetrix GeneTitan system (software version 4.3.0.1592).

scan_protocol: Arrays were scanned using the Affymetrix GeneTitan system (software version 4.3.0.1592).

data_processing: The raw microarray data (.CEL files) were processed in the publicly available software R (www.r-project.org) using a modified version of the “affy” package and Human Entrez Gene custom CDF annotation version 19 (http://brainarray.mbni.med.umich.edu/Brainarray/Database/CustomCDF/genomic_curated_CDF.asp) using the Robust Multichip Average (RMA) method. Post-hybridization quality control checks were performed using RNA degradation score, relative log expression (RLE), and normalized unscaled standard errors (NUSE). Data were batch corrected using an implementation of ComBat v3 within the GenePattern pipeline (http://www.GenePattern.org). To remove background, we calculated the median values of all probe sets and removed those probes with expression values below the lowest median value + 1 standard deviation using a custom Perl script. This yielded 25,561 probe sets upon which subsequent analyses were based. Statistical analyses were performed using Significance Analysis of Microarrays method implemented in the MultiExperiment Viewer application.

source_name: skin, inverse psoriasis

label_protocol: cDNA were prepared according to the Nugen Ovation PicoSL WTA System V2 kit protocol from 100 ng total RNA from FFPE tissues (Ovation PicoSL WTA System V2 Manual, P/N M01226 v4).  Subsequently, Biotinylated cDNA were prepared according to the Nugen Encore Biotin Module from 2.5 ug of cDNA (Encore Biotin Module Manual, P/N M01111 v6).

extract_protocol: RNA extraction was performed with an E.Z.N.A. FFPE RNA isolation kit (Omega Bio-tek, Norcross, GA) using the xylene-based extraction method as specified by manufacturer and five 20µm thick FFPE sections of biopsy. RNA was eluted into water and stored at -80°C until analyzed.

treatment_protocol: formalin-fixed, paraffin-embedded skin biopsies

value: skin

value: inverse psoriasis


title: Skin Inverse Psoriasis 37


title: ss90 H6.P2


title: Skin Inverse Psoriasis 36


title: Skin Inverse Psoriasis 39


title: Skin Inverse Psoriasis 38


title: Skin Inverse Psoriasis 34


title: Skin Inverse Psoriasis 35


title: ss84 G12.P2


title: Skin Inverse Psoriasis 32


title: Skin Inverse Psoriasis 33


title: ss91 H7.P2


title: Skin Inverse Psoriasis 29


title: Skin Inverse Psoriasis 30


title: Skin Inverse Psoriasis 28


title: SS2 A2.P2


title: ss92 H8.P2


title: ss66 F6 D.P3


title: SS3 A3.P2


title: Skin Inverse Psoriasis 31


title: Skin Inverse Psoriasis 25


title: Skin Inverse Psoriasis 26


title: Skin Inverse Psoriasis 24


title: SS6 A6.P2


title: Skin Inverse Psoriasis 21


title: Skin Inverse Psoriasis 22


title: ss43 D7 TKI.P1

description:
CML_Plate1_PatNr.7_TKI
All patients included in this dataset responded well to TKI, but leukemic cells (Ph+) can still be detected in patient bone marrow.


title: ss49 E1 D.P1

description:
CML_Plate1_PatNr.7_Dx
All patients included in this dataset responded well to TKI, but leukemic cells (Ph+) can still be detected in patient bone marrow.


title: ss44 D8 TKI.P1


title: Skin Inverse Psoriasis 20


title: Skin Inverse Psoriasis 23


title: Skin Inverse Psoriasis 27


title: ss50 E2 D.P1


title: Skin Inverse Psoriasis 17


title: Skin Inverse Psoriasis 16


title: Skin Inverse Psoriasis 15


title: Skin Inverse Psoriasis 14


title: Skin Inverse Psoriasis 13


title: Skin Inverse Psoriasis 12


title: Skin Inverse Psoriasis 18


title: ss45 D9 TKI.P1


title: Skin Inverse Psoriasis 9


title: Skin Inverse Psoriasis 11


title: Skin Inverse Psoriasis 19


title: Skin Inverse Psoriasis 10


title: ss46 D10 TKI.P1


title: ss52 E4 D.P1


title: ss92 H8 TKI.P3


title: ss51 E3 D.P1


title: Skin Inverse Psoriasis 5


title: ss47 D11 TKI.P1


title: ss53 E5 D.P1


title: ss48 D12 TKI.P1


title: Skin Inverse Psoriasis 8


title: Skin Inverse Psoriasis 4


title: Skin Inverse Psoriasis 6


title: ss54 E6 D.P1


title: Skin Inverse Psoriasis 3


title: Skin Erythrodermic Psoriasis 29

source_name: skin, erythrodermic psoriasis

value: erythrodermic psoriasis


title: ss55 E7 TKI.P1


title: Skin Inverse Psoriasis 2


title: Skin Inverse Psoriasis 7


title: Skin Inverse Psoriasis 1


title: ss37 D1 D.P1


title: Skin Erythrodermic Psoriasis 30


title: Skin Erythrodermic Psoriasis 28


title: Skin Erythrodermic Psoriasis 25


title: Skin Erythrodermic Psoriasis 26


title: ss38 D2 D.P1


title: Skin Erythrodermic Psoriasis 23


title: Skin Erythrodermic Psoriasis 24


title: Skin Erythrodermic Psoriasis 20


title: Skin Erythrodermic Psoriasis 22


title: ss56 E8 TKI.P1


title: Skin Erythrodermic Psoriasis 18


title: Skin Erythrodermic Psoriasis 17


title: ss39 D3 D.P1


title: Skin Erythrodermic Psoriasis 27


title: Skin Erythrodermic Psoriasis 15


title: Skin Erythrodermic Psoriasis 19


title: ss57 E9 TKI.P1


title: Skin Erythrodermic Psoriasis 21


title: Skin Erythrodermic Psoriasis 12


title: ss40 D4 D.P1


title: ss41 D5 D.P1


title: Skin Erythrodermic Psoriasis 11


title: Skin Erythrodermic Psoriasis 14


title: ss59 E11 TKI.P1


title: ss58 E10 TKI.P1


title: Skin Erythrodermic Psoriasis 10


title: Skin Erythrodermic Psoriasis 13


title: Skin Erythrodermic Psoriasis 9


title: Skin Erythrodermic Psoriasis 7


title: Skin Erythrodermic Psoriasis 6


title: Skin Erythrodermic Psoriasis 16


title: Skin Erythrodermic Psoriasis 5


title: ss32 C8 TKI.P1


title: ss42 D6 D.P1


title: ss31 C7 TKI.P1


title: ss61 F1 D.P1


title: ss62 F2 D.P1


title: Skin Erythrodermic Psoriasis 3


title: ss33 C9 TKI.P1


title: ss63 F3 D.P1


title: Skin Erythrodermic Psoriasis 2


title: ss64 F4 D.P1


title: ss34 C10 TKI.P1


title: Skin Normal 20

source_name: skin, normal healthy

value: normal healthy


title: ss35 C11 TKI.P1


title: Skin Normal 18


title: Skin Erythrodermic Psoriasis 4


title: ss36 C12 TKI.P1


title: ss65 F5 D.P1


title: Skin Normal 17


title: ss26 C2 D.P1


title: ss25 C1 D.P1


title: Skin Normal 15


title: ss68 F8 TKI.P1


title: Skin Erythrodermic Psoriasis 1


title: Skin Normal 16


title: Skin Normal 14


title: ss28 C4 D.P1


title: ss66 F6 D.P1


title: Skin PlaquePsoriasis 09

source_name: skin, plaque psoriasis lesion

value: plaque psoriasis lesion


title: ss70 F10 TKI.P1


title: ss71 F11 TKI.P1


title: Skin PlaquePsoriasis 12


title: Skin PlaquePsoriasis 11


title: Skin PlaquePsoriasis 10


title: ss27 C3 D.P1


title: Skin PlaquePsoriasis 08


title: Skin Normal 13


title: Skin Normal 19


title: ss69 F9 TKI.P1


title: Skin PlaquePsoriasis 07


title: Skin PlaquePsoriasis 04


title: ss30 C6 D.P1


title: ss20 B8 TKI.P1


title: Skin PlaquePsoriasis 05


title: ss73 G1 D.P1


title: Skin PlaquePsoriasis 03


title: Skin PlaquePsoriasis 06


title: ss74 G2 D.P1


title: Skin PlaquePsoriasis 02


title: Skin Normal 12


title: ss21 B9 TKI.P1


title: Skin PlaquePsoriasis 01


title: ss19 B7 TKI.P1


title: ss23 B11 TKI.P1


title: Skin Normal 08


title: Skin Normal 10


title: ss77 G5 D.P1


title: ss24 B12 TKI.P1


title: ss22 B10 TKI.P1


title: ss78 G6 D.P1


title: Skin Normal 11


title: Skin Normal 05


title: Skin Normal 07


title: SS13 B1 D.P1


title: Skin Normal 06


title: Skin Normal 03


title: Skin Normal 04


title: ss79 G7 TKI.P1


title: ss75 G3 D.P1


title: SS14 B2 D.P1


title: Skin Normal 02


title: ss76 G4 D.P1


title: Skin Normal 09


title: SS15 B3 D.P1


title: Skin Normal 01


title: Skin_GeneralizedPustularPsoriasis_31

description:
H5_GPP_112_Redo.CEL
SAMPLE 63

hyb_protocol: standard Affymetrix protocol

scan_protocol: standard Affymetrix protocol

source_name: skin_generalized pustular psoriasis lesion

label_protocol: standard Affymetrix protocol

tag: tissue status

value: generalized pustular psoriasis (GPP) lesion


title: Skin_GeneralizedPustularPsoriasis_32

description:
H5_GPP_113_Redo.CEL
SAMPLE 64


title: Skin_GeneralizedPustularPsoriasis_29

description:
H4_Pustular_089.CEL
SAMPLE 61


title: ss81 G9 TKI.P1


title: ss82 G10 TKI.P1


title: Skin_GeneralizedPustularPsoriasis_30

description:
H5_GPP_111_Redo.CEL
SAMPLE 62


title: ss16 B4 D.P1


title: ss83 G11 TKI.P1


title: ss80 G8 TKI.P1


title: ss18 B6 D.P1


title: SS7 A7 TKI.P1


title: ss17 B5 D.P1


title: SS8 A8 TKI.P1


title: SS9 A9 TKI.P1


title: Skin_GeneralizedPustularPsoriasis_28

description:
H4_Pustular_088.CEL
SAMPLE 60


title: Skin_GeneralizedPustularPsoriasis_27

description:
H4_Pustular_087.CEL
SAMPLE 59


title: ss87 H3 D.P1


title: Skin_GeneralizedPustularPsoriasis_22

description:
H4_Pustular_082.CEL
SAMPLE 54


title: Skin_GeneralizedPustularPsoriasis_26

description:
H4_Pustular_086.CEL
SAMPLE 58


title: Colon endothelial cells-day+2-syngeneic-biological rep 3

city: Berlin

first: Katarina

last: Riesner

address: Augustenburger Platz 1

department: Hematology, Oncolgy and Tumorimmunology

country: Germany

institute: Charité University Medicine

hyb_protocol: Following fragmentation, 3.8 µg of fragmented and labeled ss-DNA (final koncentration 25 ng/µl) were hybridized for 16h at 45°C on GeneChip Mogene 2.0 Array.

scan_protocol: GeneChips were scanned using the GeneChip Scanner 7G from Affymetrix.

data_processing: Gene level normalization and signal summarization were performed with Expression Console 1.4.1 using Affymetrix default analysis settings of the 3'Expression array RMA workflow. RMA workflow is Quantile normalization and has a general background correction.

source_name: Endothelial cells from colon of syngeneic transplanted mouse

label_protocol: Biotinylated cRNA was prepared according to the Affymetrix protocol GeneChip WT Pico Reagent Kit from 700pg total RNA (Manual Target Preparation for GeneChip Whole Transcript (WT) Expression Arrays, User Guide 2015-2016, Affymetrix).

growth_protocol: Female C57BL/6 mice were treated for 5 days with busulfane/cyclophosphamide conditioning and were transplanted with 1.5x10^7 bone marrow and 2x10^6 T cells from C57BL/6 (syngeneic) and LP/J (allogeneic) recipients.

extract_protocol: Total RNA extraction was performed with the mirVana miRNA Isolation Kit (Life Technologies) according to manufacturer´s instructions.

treatment_protocol: At day+2 after transplantation, colon was harvested from mice and single cell suspension was obtained by 1 mg/ml collagenase IV digestion for 60 min at 37°C and continous shaking. Endothelial cells from colon single cell suspension were obtained by CD45-CD11b-CD31+ FACS sorting. Sorted cells were immediatly processed to RNA isolation.

tag: recipient strain

tag: gender

value: female

tag: donor strain

tag: day after transplantation

tag: cells

value: endothelial cells

value: colon


title: Colon endothelial cells-day+2-syngeneic-biological rep 4


title: Skin_GeneralizedPustularPsoriasis_23

description:
H4_Pustular_083.CEL
SAMPLE 55


title: Skin_GeneralizedPustularPsoriasis_25

description:
H4_Pustular_085.CEL
SAMPLE 57


title: Skin_GeneralizedPustularPsoriasis_24

description:
H4_Pustular_084.CEL
SAMPLE 56


title: Skin_GeneralizedPustularPsoriasis_21

description:
H4_Pustular_081.CEL
SAMPLE 53


title: ss88 H4 D.P1

value: CML

tag: cell type


title: SS11 A11 TKI.P1


title: Skin_GeneralizedPustularPsoriasis_19

description:
H4_Pustular_079.CEL
SAMPLE 51


title: Colon endothelial cells-day+2-syngeneic-biological rep 1


title: Colon endothelial cells-day+2-syngeneic-biological rep 2


title: Colon endothelial cells-day+2-allogeneic-biological rep 4

source_name: Endothelial cells from colon of allogeneic transplanted mouse

value: LP/J


title: Skin_GeneralizedPustularPsoriasis_18

description:
H4_Pustular_078.CEL
SAMPLE 50


title: SS12 A12 TKI.P1

value: CML Bone Marrow HSC


title: SS10 A10 TKI.P1

value: after TKI treatment (TKI)


title: SS1 A1 D.P1

value: at diagnosis (Dx)


title: ss91 H7 TKI.P1

value: Ph+ detected in BM (but all cells are not Ph+)


title: SS2 A2 D.P1


title: Skin_GeneralizedPustularPsoriasis_20

description:
H4_Pustular_080.CEL
SAMPLE 52


title: Colon endothelial cells-day+2-allogeneic-biological rep 2


title: Skin_GeneralizedPustularPsoriasis_16

description:
H2_Pustular_044.CEL
SAMPLE 48


title: ss90 H6 D.P1


title: ss89 H5 D.P1


title: Skin_GeneralizedPustularPsoriasis_17

description:
H4_Pustular_073.CEL
SAMPLE 49


title: SS3 A3 D.P1


title: Skin_GeneralizedPustularPsoriasis_11

description:
H2_Pustular_038.CEL
SAMPLE 43


title: Skin_GeneralizedPustularPsoriasis_15

description:
H2_Pustular_043.CEL
SAMPLE 47


title: Colon endothelial cells-day+2-allogeneic-biological rep 3


title: Skin_GeneralizedPustularPsoriasis_14

description:
H2_Pustular_042.CEL
SAMPLE 46


title: Colon endothelial cells-day+2-allogeneic-biological rep 1


title: ss92 H8 TKI.P1


title: Skin_GeneralizedPustularPsoriasis_12

description:
H2_Pustular_040.CEL
SAMPLE 44


title: Skin_GeneralizedPustularPsoriasis_10

description:
H2_Pustular_037.CEL
SAMPLE 42


title: Skin_GeneralizedPustularPsoriasis_13

description:
H2_Pustular_041.CEL
SAMPLE 45


title: ss 93 H9 TKI.P1


title: Skin_GeneralizedPustularPsoriasis_09

description:
H2_Pustular_035.CEL
SAMPLE 41


title: Skin_GeneralizedPustularPsoriasis_08

description:
H2_Pustular_033.CEL
SAMPLE 40


title: reference male mouse2/ 0GyD8

value: tail


title: SS4 A4 D.P1


title: ss67 F7 TKI.P1


title: SS5 A5 D.P1


title: ss95 H11 TKI.P1


title: ss43 D7 TKI.P0

description:
CML_Plate2_PatNr.7_TKI
All patients included in this dataset responded well to TKI, but leukemic cells (Ph+) can still be detected in patient bone marrow.


title: SS6 A6 D.P1


title: ss44 D8 TKI.P0


title: Skin_GeneralizedPustularPsoriasis_05

description:
H2_Pustular_030.CEL
SAMPLE 37


title: Skin_GeneralizedPustularPsoriasis_06

description:
H2_Pustular_031.CEL
SAMPLE 38


title: Skin_GeneralizedPustularPsoriasis_07

description:
H2_Pustular_032.CEL
SAMPLE 39


title: ss94 H10 TKI.P1


title: 0GyD7/ reference male mouse2


title: 0GyD8/ reference male mouse2


title: Skin_GeneralizedPustularPsoriasis_01

description:
H2_Pustular_025.CEL
SAMPLE 33


title: Skin_GeneralizedPustularPsoriasis_04

description:
H2_Pustular_029.CEL
SAMPLE 36


title: 0GyD6/ reference male mouse2


title: reference male mouse2/ 0GyD5


title: Skin_PlaquePsoriasis_12

description:
H1_Plaque_024.CEL
SAMPLE 32

source_name: skin_plaque psoriasis lesion

value: chronic plaque psoriasis lesion


title: Skin_GeneralizedPustularPsoriasis_02

description:
H2_Pustular_027.CEL
SAMPLE 34

value: skin


title: 0GyD5/ reference male mouse2


title: reference male mouse2/ 0GyD7


title: 0GyDF/ reference male mouse2


title: reference male mouse2/ 0GyDF


title: ss50 E2 D.P0

description:
CML_Plate2_PatNr.7_Dx
All patients included in this dataset responded well to TKI, but leukemic cells (Ph+) can still be detected in patient bone marrow.


title: reference male mouse2/ 0GyD6


title: Skin_PlaquePsoriasis_11

description:
H1_Plaque_023.CEL
SAMPLE 31


title: ss49 E1 D.P0


title: 0GyDM/ reference male mouse2


title: ss29 C5 D.P1


title: ss51 E3 D.P0


title: ss45 D9 TKI.P0


title: Skin_PlaquePsoriasis_10

description:
H1_Plaque_022.CEL
SAMPLE 30


title: ss52 E4 D.P0


title: ss46 D10 TKI.P0


title: ss47 D11 TKI.P0


title: reference male mouse2/ 0GyDM


title: Skin_PlaquePsoriasis_09

description:
H1_Plaque_021.CEL
SAMPLE 29


title: ss48 D12 TKI.P0


title: Skin_PlaquePsoriasis_08

description:
H1_Plaque_020.CEL
SAMPLE 28


title: Skin_PlaquePsoriasis_07

description:
H1_Plaque_019.CEL
SAMPLE 27


title: ss54 E6 D.P0


title: ss37 D1 D.P0


title: Skin_PlaquePsoriasis_06

description:
H1_Plaque_018.CEL
SAMPLE 26


title: 0GyC6/ reference male mouse4

source_name: reference male mouse4


title: Skin_PlaquePsoriasis_05

description:
H1_Plaque_017.CEL
SAMPLE 25


title: 0GyC5/ reference male mouse4


title: reference male mouse4/ 0GyC6


title: Skin_PlaquePsoriasis_03

description:
H1_Plaque_015.CEL
SAMPLE 23


title: ss55 E7 TKI.P0


title: Skin_PlaquePsoriasis_04

description:
H1_Plaque_016.CEL
SAMPLE 24


title: ss53 E5 D.P0


title: reference male mouse4/ 0GyC5


title: Skin_GeneralizedPustularPsoriasis_03

description:
H2_Pustular_028.CEL
SAMPLE 35


title: Skin_Normal_20

description:
H4_Normal_096.CEL
SAMPLE 20

source_name: skin_normal healthy


title: Skin_PlaquePsoriasis_01

description:
H1_Plaque_013.CEL
SAMPLE 21


title: 0GyC4/ reference male mouse4


title: reference male mouse4/ 0GyC4


title: 0GyC3/ reference male mouse4


title: reference male mouse4/ 0GyC3


title: ss56 E8 TKI.P0


title: 0GyC2/ reference male mouse4


title: ss57 E9 TKI.P0


title: ss39 D3 D.P0


title: ss40 D4 D.P0


title: ss58 E10 TKI.P0


title: ss41 D5 D.P0


title: reference male mouse4/ 0GyC2


title: Skin_PlaquePsoriasis_02

description:
H1_Plaque_014.CEL
SAMPLE 22


title: Skin_Normal_17

description:
H4_Normal_093.CEL
SAMPLE 17


title: Skin_Normal_14

description:
H2_Normal_046.CEL
SAMPLE 14


title: 0GyC1/ reference male mouse4


title: Skin_Normal_15

description:
H2_Normal_047.CEL
SAMPLE 15


title: Skin_Normal_18

description:
H4_Normal_094.CEL
SAMPLE 18


title: Skin_Normal_19

description:
H4_Normal_095.CEL
SAMPLE 19


title: Skin_Normal_13

description:
H2_Normal_045.CEL
SAMPLE 13


title: reference male mouse4/ 0GyCM


title: 0GyCM/ reference male mouse4


title: ss59 E11 TKI.P0


title: 0GyCF/ reference male mouse4


title: Skin_Normal_16

description:
H2_Normal_048.CEL
SAMPLE 16


title: reference male mouse4/ 0GyC1


title: reference male mouse4/ 0GyCF


title: ss32 C8 TKI.P0


title: reference male mouse4/ 0GyB6


title: ss31 C7 TKI.P0


title: 0GyB6/ reference male mouse4


title: ss61 F1 D.P0


title: ss42 D6 D.P0


title: ss33 C9 TKI.P0


title: ss34 C10 TKI.P0


title: ss62 F2 D.P0


title: ss63 F3 D.P0


title: ss64 F4 D.P0


title: ss35 C11 TKI.P0


title: ss65 F5 D.P0


title: ss36 C12 TKI.P0


title: ss66 F6 D.P0


title: ss25 C1 D.P0


title: Skin_Normal_04

description:
H1_Normal_004.CEL
SAMPLE 4


title: Skin_Normal_10

description:
H1_Normal_010.CEL
SAMPLE 10


title: 0GyB5/ reference male mouse4


title: Skin_Normal_11

description:
H1_Normal_011.CEL
SAMPLE 11


title: Skin_Normal_03

description:
H1_Normal_003.CEL
SAMPLE 3


title: Skin_Normal_12

description:
H1_Normal_012.CEL
SAMPLE 12


title: Skin_Normal_09

description:
H1_Normal_009.CEL
SAMPLE 9


title: ss38 D2 D.P0


title: Skin_Normal_06

description:
H1_Normal_006.CEL
SAMPLE 6


title: Skin_Normal_05

description:
H1_Normal_005.CEL
SAMPLE 5


title: Skin_Normal_07

description:
H1_Normal_007.CEL
SAMPLE 7


title: Skin_Normal_01

description:
H1_Normal_001.CEL
SAMPLE 1


title: Skin_Normal_08

description:
H1_Normal_008.CEL
SAMPLE 8


title: ss67 F7 TKI.P0


title: peripheral blood sample obtained from celiac patient Z (100351_Zv6)

tag: individual

value: celiac patient Z

value: biopsy confirmed celiac disease on gluten-free diet greater than one year

value: 6 weeks gluten challenge

value: peripheral whole blood

value: purified pool of B and T cells


title: Skin_Normal_02

description:
H1_Normal_002.CEL
SAMPLE 2

value: normal healthy


title: reference male mouse4/ 0GyB1


title: 0GyB1/ reference male mouse4


title: reference male mouse4/ 0GyBF


title: reference male mouse4/ 0GyB3


title: reference male mouse4/ 0GyB2


title: peripheral blood sample obtained from celiac patient Y (100359_Yv6)

value: celiac patient Y

tag: disease state


title: 0GyBF/ reference male mouse4


title: 0GyB2/ reference male mouse4


title: peripheral blood sample obtained from celiac patient Z (100350_Zv2)

tag: treatment

value: control


title: ss26 C2 D.P0

value: CML


title: ss68 F8 TKI.P0


title: ss27 C3 D.P0


title: 0GyB3/ reference male mouse4

tag: tissue


title: 0GyBM/ reference male mouse4


title: peripheral blood sample obtained from celiac patient Y (100358_Yv2)

tag: biopsy data, villus height to crypt depth


title: ss69 F9 TKI.P0


title: ss28 C4 D.P0


title: ss70 F10 TKI.P0


title: peripheral blood sample obtained from celiac patient X (100352_Xv2)

value: celiac patient X

tag: hybridization batch


title: peripheral blood sample obtained from celiac patient X (100353_Xv6)


title: reference male mouse4/ 0GyBM

tag: strain


title: 0GyI6/ reference male mouse2


title: peripheral blood sample obtained from celiac patient V (100344_Vv2)

value: celiac patient V


title: peripheral blood sample obtained from celiac patient W (100361_Wv6)

value: celiac patient W


title: reference male mouse4/ 0GyB5


title: 0GyB4/ reference male mouse4


title: ss29 C5 D.P0

tag: clinical phase

value: at diagnosis (Dx)

value: CML Bone Marrow HSC


title: reference male mouse4/ 0GyB4

value: tail


title: reference male mouse2/ 0GyI6


title: reference male mouse2/ 0GyI5


title: peripheral blood sample obtained from celiac patient V (100345_Vv6)


title: ss71 F11 TKI.P0

value: after TKI treatment (TKI)

tag: therapy-response

value: Ph+ detected in BM (but all cells are not Ph+)


title: reference male mouse2/ 0GyI4


title: peripheral blood sample obtained from celiac patient W (100360_Wv2)


title: 0GyI4/ reference male mouse2


title: 0GyI5/ reference male mouse2


title: ss30 C6 D.P0

tag: cell subtype


title: 0GyI3/ reference male mouse2


title: ss73 G1 D.P0


title: ss19 B7 TKI.P0


title: ss20 B8 TKI.P0


title: ss74 G2 D.P0


title: ss75 G3 D.P0


title: ss21 B9 TKI.P0


title: peripheral blood sample obtained from celiac patient U (100357_Uv6)

value: celiac patient U


title: peripheral blood sample obtained from celiac patient T (100341_Tv6)

value: celiac patient T

value: biopsy confirmed celiac disease on gluten-free diet greater than one year


title: peripheral blood sample obtained from celiac patient S (100331_Sv6)

value: celiac patient S

value: 6 weeks gluten challenge

value: peripheral whole blood


title: 0GyI2/ reference male mouse2


title: peripheral blood sample obtained from celiac patient U (100356_Uv2)

value: purified pool of B and T cells


title: peripheral blood sample obtained from celiac patient S (100330_Sv2)

value: control


title: peripheral blood sample obtained from celiac patient Q (100335_Qv6)

value: celiac patient Q


title: reference male mouse2/ 0GyI2


title: peripheral blood sample obtained from celiac patient Q (100334_Qv2)


title: peripheral blood sample obtained from celiac patient R (100355_Rv6)

value: celiac patient R


title: reference male mouse2/ 0GyIF


title: ss76 G4 D.P0

value: CML


title: peripheral blood sample obtained from celiac patient P (100347_Pv6)

value: celiac patient P


title: reference male mouse2/ 0GyI3


title: 0GyI1/ reference male mouse2


title: reference male mouse2/ 0GyIM


title: 0GyIF/ reference male mouse2


title: reference male mouse2/ 0GyI1


title: 0GyIM/ reference male mouse2


title: ss23 B11 TKI.P0


title: ss24 B12 TKI.P0


title: ss77 G5 D.P0

value: at diagnosis (Dx)


title: SS13 B1 D.P0

value: CML Bone Marrow HSC


title: ss78 G6 D.P0


title: peripheral blood sample obtained from celiac patient R (100354_Rv2)


title: Skin Erythrodermic Psoriasis 8

value: skin

value: erythrodermic psoriasis


title: peripheral blood sample obtained from celiac patient O (100332_Ov2)

value: celiac patient O


title: peripheral blood sample obtained from celiac patient O (100333_Ov6)


title: peripheral blood sample obtained from celiac patient N (100328_Nv2)

value: celiac patient N


title: peripheral blood sample obtained from celiac patient L (100336_Lv2)

value: celiac patient L


title: peripheral blood sample obtained from celiac patient N (100329_Nv6)

value: biopsy confirmed celiac disease on gluten-free diet greater than one year


title: peripheral blood sample obtained from celiac patient M (100320_Mv2)

value: celiac patient M


title: ss79 G7 TKI.P0

value: after TKI treatment (TKI)

value: Ph+ detected in BM (but all cells are not Ph+)


title: peripheral blood sample obtained from celiac patient L (100337_Lv6)

value: 6 weeks gluten challenge

value: peripheral whole blood

value: purified pool of B and T cells


title: reference male mouse2/ 0GyH7

value: tail


title: reference male mouse2/ 0GyH6


title: SS14 B2 D.P0

value: CML


title: 0GyH7/ reference male mouse2


title: peripheral blood sample obtained from celiac patient M (100321_Mv6)


title: peripheral blood sample obtained from celiac patient P (100346_Pv2)

value: celiac patient P

value: control


title: ss16 B4 D.P0

value: at diagnosis (Dx)

value: CML Bone Marrow HSC


title: SS15 B3 D.P0


title: ss80 G8 TKI.P0


title: reference male mouse2/ 0GyH8


title: ss81 G9 TKI.P0


title: peripheral blood sample obtained from celiac patient K (100343_Kv6)

value: celiac patient K


title: peripheral blood sample obtained from celiac patient H (100339_Hv6)

value: celiac patient H


title: 0GyH8/ reference male mouse2


title: reference male mouse2/ 0GyH4


title: 0GyH6/ reference male mouse2


title: ss18 B6 D.P0


title: 0GyH5/ reference male mouse2


title: ss17 B5 D.P0


title: 0GyH4/ reference male mouse2


title: ss22 B10 TKI.P0


title: SS7 A7 TKI.P0


title: 0GyH2/ reference male mouse2


title: ss83 G11 TKI.P0


title: peripheral blood sample obtained from celiac patient G (100348_Gv2)

value: celiac patient G


title: SS9 A9 TKI.P0


title: SS8 A8 TKI.P0


title: SS10 A10 TKI.P0


title: peripheral blood sample obtained from celiac patient K (100342_Kv2)


title: ss87 H3 D.P0


title: 0GyH3/ reference male mouse2


title: peripheral blood sample obtained from celiac patient G (100349_Gv6)


title: 0GyH1/ reference male mouse2


title: peripheral blood sample obtained from celiac patient H (100338_Hv2)


title: ss88 H4 D.P0


title: peripheral blood sample obtained from celiac patient A (100324_Av2)

value: celiac patient A


title: peripheral blood sample obtained from celiac patient C (100327_Cv6)

value: celiac patient C

value: biopsy confirmed celiac disease on gluten-free diet greater than one year


title: reference male mouse2/ 0GyH3


title: peripheral blood sample obtained from celiac patient C (100326_Cv2)


title: peripheral blood sample obtained from celiac patient A (100325_Av6)


title: SS11 A11 TKI.P0

value: after TKI treatment (TKI)


title: reference male mouse2/ 0GyH5


title: reference male mouse2/ 0GyH2


title: reference male mouse2/ 0GyHF


title: ss82 G10 TKI.P0

value: Ph+ detected in BM (but all cells are not Ph+)


title: 0GyHF/ reference male mouse2


title: reference male mouse2/ 0GyH1


title: SS12 A12 TKI.P0


title: 0GyHM/ reference male mouse2


title: ss90 H6 D.P0


title: ss89 H5 D.P0


title: reference male mouse2/ 0GyHM


title: SS1 A1 D.P0


title: 0GyG6/ reference male mouse2


title: ss91 H7 TKI.P0


title: 0GyE6/ reference male mouse1

source_name: reference male mouse1


title: reference male mouse1/ 0GyE6


title: 0GyE5/ reference male mouse1


title: reference male mouse2/ 0GyG6


title: 0GyG5/ reference male mouse2


title: SS2 A2 D.P0


title: reference male mouse1/ 0GyE4


title: 0GyE4/ reference male mouse1


title: reference male mouse1/ 0GyE5


title: 0GyG3/ reference male mouse2


title: ss92 H8 TKI.P0


title: 0GyG4/ reference male mouse2


title: reference male mouse2/ 0GyG5


title: reference male mouse2/ 0GyG4


title: SS3 A3 D.P0